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ABSTRACT 
Murine infection by the Lyme disease spirochete, B. burgdorferi, results in the generation 
of pathogen-specific antibody that can provide protection against Lyme disease, but the 
cells involved in this response are poorly characterized.  T cells are not required for 
generating a protective antibody response to B. burgdorferi infection, but their exact role 
in providing protection against tissue colonization had not been previously determined.  
We found that TCRβxδ-/- mice were susceptible to high pathogen loads and decreased 
antibody titers, but inhibition of CD40L-dependent interactions resulted in partial 
protection suggesting that a portion of the help provided by T cells was not dependent on 
CD40L-CD40 interactions between T and B cells.  RAG1-/- mice reconstituted with either 
un-fractionated or B1-enriched peritoneal cells from previously infected mice generated 
B. burgdorferi-specific antibody, and upon spirochetal challenge suffered significantly 
lower levels of pathogen load in the joint and heart.  Peritoneal cells from previously 
infected TCRβxδ-/- mice or B2-enriched or B1-purified peritoneal cells conferred little to 
only moderate protection, suggesting T cells play an important role in protection against 
spirochetal infection the joint. Consistent with this, T cells from previously infected 
donor mice, when transferred with B1 or B2 cells into RAG1-/- mice, generated increased 
antibody titers and were capable of diminishing bacterial burden in the joint and heart.  A 
previously identified class of protective antibody is directed against the spirochetal 
surface lipoprotein DbpA, and we found that DbpA is a prominent protein antigen 
recognized by RAG1-/- mice reconstituted with B1-enriched peritoneal cells.  
Additionally, we found that mice reconstituted with B1 cells also make antibody directed 
  
vii
towards the spirochetal glycolipid antigen, BbGL-IIc, which is recognized by Vα14iNKT 
cells.  Consistent with the idea that T cells are important in providing protection against 
spirochetal infection, RAG1-/- mice reconstituted with B1 and T cells generated a more 
robust response against DbpA and BbGL-IIc.  These results support the hypothesis that T 
cells act with B1 cells in a CD40L-independent manner to promote the production of 
antibodies that play an important role in protection of the joint from spirochetal infection. 
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CHAPTER I 
 
INTRODUCTION 
 
Lyme Disease 
Lyme disease is the most common vector-borne illness in the United States:  more than 
28,000 cases were reported in the United States in 2008 ,with most cases occurring in the 
northeastern and north-central states [1].  Borrelia burgdorferi sensu lato, the causative 
agent of Lyme disease, is carried by Ixodes scapularis ticks [2].  The tick feeds on 
mammals for several days, and within approximately two days of feeding, the spirochetes 
travel from the tick’s midgut into the salivary glands and then into the mammalian skin 
[3].  Both nymph and adult ticks can cause human transmission, but nymphal ticks are 
quite small (~size of a poppy seed) and so are more likely to go unnoticed for the time it 
takes transmission to occur.  
 
Once transmitted into its human host, B. burgdorferi causes a complex, multi-system 
infection.  Human Lyme disease occurs in stages (reviewed in [4, 5]).  The first stage is 
an early, localized infection which occurs within 3-32 days of the tick bite.  About 70-
80% of infected individuals present with erythema migrans (EM), a slowly expanding 
skin lesion typically referred to as a ‘bull’s eye” rash.  Spirochetes can be cultured from 
this rash, which expands as the spirochetes migrate away from the site of the bite [6].  
Flu-like symptoms such as fatigue, headache, joint and muscle pain and fever can also 
occur. If detected early, Lyme disease is easily treated with antibiotics. 
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Within days to weeks after the onset of disease, B. burgdorferi may disseminate (second 
stage).  At this stage, clinical manifestations may include secondary EM lesions, 
continuation of flu-like symptoms and joint and muscle pain with additional cardiac and 
neurological involvement.  These signs and symptoms may resolve.  However, in some 
instances, infection can persist (third stage), resulting in chronic manifestations of Lyme 
disease, which can occur weeks, months, and even years after dissemination — 
manifestations of acute systemic illness include severe fatigue, numbness and tingling in 
the extremities or back, partial facial nerve paralysis, neurological changes including 
problems with memory, mood or sleep.  Heart problems may less frequently develop, but 
if left untreated, ~60% of patients will develop intermittent bouts of arthritis with severe 
joint pain and swelling, usually in the knee.   
 
Mouse Model of Infection 
An invaluable tool for the study of Lyme disease is the laboratory mouse model 
(reviewed in[7]).  Upon intradermal inoculation, B. burgdorferi can colonize at the site of 
injection and within a few days will disseminate to distant sites such as the heart, joint, 
bladder and ear.  Arthritis can begin to develop as early as 4 days after infection followed 
by carditis in 7 to 10 days.  Bacteria can be precisely measured in tissue sites by 
quantitative PCR (qPCR) and show that although there is some mouse strain-dependent 
variation, spirochetes are generally high at 2 to 4 weeks then slowly resolve.  However, 
mice can become chronically infected at several of these sites and bacteria have been 
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detected at several tissue sites up to 6 to 12 months after infection in the absence of 
disease[8].   
 
Although unlike human Lyme disease, intradermally infected mice do not develop 
neurological or skin manifestations, they do suffer a multi-system infection leading to 
arthritis and carditis, each coinciding with invasion and proliferation of spirochetes in the 
respective tissues [9]. Disease susceptibility in laboratory inbred mouse strains is 
genetically determined.  Mouse strains commonly used for studying Lyme disease 
include C3H, C57BL/6 (B6) and BALB/c mice.  C3H mice were shown to acquire the 
most severe disease as well as higher titers of IgG antibody compared to B6 and BALB/c 
mice [10].  Further work examined the effects of increasing the infectious dose on disease 
outcome.  C3H mice presented with severe arthritis at all doses tested with as little as 200 
bacteria [11].  B6 mice had mild to moderate arthritis at all doses tested even though 
spirochete numbers were equivalent to those found in severely diseased C3H mice.  
BALB/c mice showed intermediate susceptibility which was dose-dependent.  Thus, the 
outcome of experimental infections can be affected by the chosen mouse strain since 
there is an as yet unidentified  genetic component which determines how susceptible a 
mouse is to B. burgdorferi infection. [8].   
 
Mouse Humoral Immune Response to B. burgdorferi  
Lyme disease is an illness in which the immune response is necessary for limiting 
bacterial colonization and promoting clearance, but it also contributes to pathology.  
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Lymphocytes are not required for causing disease, because B. burgdorferi infection in 
severe combined immunodeficient mice (SCID), deficient in T and B cells, causes 
arthritis and carditis [12].  But there is speculation that T cells may in fact help to 
exacerbate disease severity.  RAG1-/- mice (lacking both B and T cells) infected with B. 
burgdorferi and reconstituted with CD4+ T cells suffered more severe arthritis and 
carditis compared to unreconstituted mice [13].  
 
An adaptive immune response is important for diminishing bacterial load and for disease 
resolution because SCID mice are unable to clear the bacteria [12].  Adoptive transfer of 
T cells from B. burgdorferi-immune mice did not protect naïve mice from challenge [14, 
15] indicating that T cells alone were not sufficient to prevent infection.  Similarly, B 
cell-deficient mice suffered from severe arthritis and carditis compared to control mice 
[13] and reconstitution of SCID mice with splenocytes enriched for B cells reduced 
disease severity and generated B. burgdorferi-specific antibodies at levels similar to 
SCID mice reconstituted with un-fractionated splenocytes [15].  Thus, the humoral 
immune response plays a particularly crucial role.    
  
Mice mount a complex antibody response upon infection with B. burgdorferi, which 
consists of IgM as well as multiple IgG isotypes, and these antibodies recognize a wide 
array of spirochetal antigens [8-10, 12].  Numerous studies have looked at the role of 
immune sera and its ability to protect against B. burgdorferi infection. Importantly, 
passive transfer of human sera from patients with late-stage Lyme disease protected mice 
  
5
against B. burgdorferi infection [16].   In addition, passive transfer of immune sera from 
infected C3H mice into SCID mice before or at the time of challenge protected SCID 
mice [17].  The protective component of immune sera was present as early as 15 days 
after infection.  
 
Antibody as an effector molecule to promote clearance of B. burgdorferi. 
Antibodies directed against the Lyme disease spirochete have been associated with 
specific effector functions in vitro.  They can bind to the surface of the spirochetes to 
activate complement-mediated killing [18, 19], they promote opsonization and 
phagocytosis [20, 21], and some are directly bactericidal in the absence of complement 
[22, 23], causing death by disruption of the outer membrane [24].   
 
One of the best-characterized B. burgdorferi antigens is decorin binding protein A 
(DbpA).  DbpA is a 20kDa surface lipoprotein which binds to decorin [25, 26], a 
proteoglycan associated with collagen fibers abundant in the extracellular matrix, as well 
as glycosaminoglycans [27].  DbpA is not expressed by B. burgdorferi while in the tick 
[28] but its expression is up-regulated once inside its mammalian host [29].  Mice 
deficient in decorin had somewhat less severe arthritis and harbored fewer spirochetes in 
their joints, a site normally abundant in decorin [30, 31].  Importantly, antibodies to 
DbpA are found in patients with late-stage Lyme disease [32] and mice seroconvert by 2 
weeks post-infection [33].  Immunization with DbpA or passive transfer of DbpA 
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antiserum protects mice from subsequent challenge with B. burgdorferi (Table 1, [34-
37]).   
 
Role of antibodies in resolution of inflammation  
B. burgdorferi-specific antibodies are essential for arthritis resolution.  Passive transfer of 
immune serum to infected mice did not clear spirochetes from tissues, but did result in 
resolution of arthritis (Table 2, [38, 39]).  In addition, CD4+ T cells may not be required 
for resolution of arthritis because mice deficient in CD4+ cells generated disease-
resolving antibodies and resolved arthritis similar to wild type mice [40].  In contrast, B. 
burgdorferi-specific antibodies may not be as critical for resolution of carditis.  Passive 
transfer of immune serum to infected SCID mice did not resolve carditis [39], and CD4+ 
T cells but not immune serum have been shown to reduce carditis [40, 41].  In contrast, 
CD4+ T cells may not be required early on in the development of carditis as macrophages 
are the predominant infiltrating cell type found in the heart in the absence of T cells [42].   
 
However, there is evidence that some B. burgdorferi-specific antibodies can resolve both 
arthritis and carditis.  Transfer of DbpA antiserum to B. burgdorferi-infected immune-
compromised mice induced carditis and arthritis remission without affecting the number 
of invading bacteria [37].  Immunohistochemical analysis showed that fewer B. 
burgdorferi were found at the heart base and synovium after transfer of anti-DbpA 
antiserum, immune serum or adoptive transfer of splenocytes and lymph node cells but 
still persisted in adjacent vessel walls, tendons and ligaments suggesting that the specific 
location of bacteria in the tissue may be an important determinant of disease.  Thus, the  
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Table 1.  DbpA as a protective antigen 
  Disease Bacterial Clearance  
Mice and Treatment1 Arthritis Carditis Culture qPCR REF 
C3H mice treated with Rabbit 
DbpA-immune serum at day 0 or 
up to 4 days post infection  
 
ND2 ND Negative ND [36] 
C3H mice treated with Rabbit 
DbpA-immune serum at 5+ days 
post infection  
ND ND Positive ND  
C3H/HeJ immunized with DbpA  ND ND Negative ND [34, 
35, 
38] 
C3H/HeJ mice immunized with 
DbpA, tick-inoculated 
ND ND 1/3 
negative 
ND [28] 
C3H SCID mice passively 
immunized with DbpA antiserum 
on days 12, 18, 24 post infection  
6/10 
positive, 
decreased 
severity 
2/5 
positive, 
decreased 
severity 
ND Positive, 
No 
change 
[37] 
1
 Mice were syringe-inoculated unless otherwise stated 
2 ND, not determined 
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humoral immune response to B. burgdorferi is essential for mediating disease resolution, 
particularly in the joint.                   
  
Cognate T cell help in promoting a humoral immune response to B. burgdorferi. 
Several classes of B cells have been identified. Among them, follicular (FO) and 
marginal zone (MZ) B cells are considered to be the conventional B (B2) cells.  Humoral 
immune responses by B cells can be T-independent or T-dependent.  Whereas MZ B cells 
and B1 cells are thought to function independently of T cells (see below) follicular (FO) 
B cells require T cell help to generate a robust humoral immune response. This “cognate” 
help is delivered upon direct interaction between FO B cells and CD4+ T cells through 
interactions between MHC class II molecules and CD40-CD40 ligand (CD40L) 
interactions.  Major histocompatibility complex (MHC) class II molecules are found on B 
cells, as well as other antigen presenting cells such as macrophages and dendritic cells, 
and present peptides that are recognized by CD4+ T cells.  Upon recognition of antigen 
and concomitant engagement of CD40L (on CD4+ T cells) and CD40 (on B cells or other 
APC’s), the B cell differentiates into an antibody-producing plasma cell. Thus, CD40L is 
required for T cell-dependent immunoglobulin synthesis and class switching from IgM to 
IgG1, IgG2b, IgG2a, and IgG3 and the generation of protective antibodies. 
 
Given the importance of antibody in protecting against B. burgdorferi infection, a number 
of studies have examined the role of CD4+ T cells during B. burgdorferi infections.  
CD4+-depleted C3H (susceptible) or BALB/c (resistant) mice displayed decreased IgG 
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Table 2.  Summary of disease resolution and bacterial clearance upon serum transfer 
  Disease Bacterial Clearance  
Donor Sera Recipient Mice1 Arthritis Carditis Culture qPCR REF 
None C3H SCID Prevalence3 
7.8 ± 0.5, 
Severity4  
3.6 ± 0.5 
Severe, 
not 
scored 
100% 
Positive 
ND [12] 
C3H 90 day immune  C3H SCID treated at time of infection None None Negative ND2 [38, 
39] 
 C3H SCID treated 4, 8 and 12 days 
post infection  
Resolved Resolved Negative ND  
 C3H SCID treated 12 days post 
infection 
4/4 Positive 4/4 
Positive 
4/4 
Positive 
ND  
 Transplant tissue-infected, C3H mice, 
treated 0, 4, 8, 12 days post infection 
Decreased 
severity, no 
change in 
prevalence 
4/5 
Positive 
5/5 
Positive 
ND  
CD40L-/- 60 day 
immune  
C.B.-17SCID treated 1 day post 
infection 
Resolved Resolved Negative ND [43] 
CIITA-deficient 
(CD4+ T cell 
deficient) 60 day 
immune 
Naive C3H 
 
C3H SCID treated 2, 4, 8 days post 
infection 
None 
 
Resolved 
None 
 
Resolved 
Negative 
 
Negative 
ND 
 
ND 
[40] 
0.1ml of 6 week 
TCRβxδ-/- immune 
C3H SCID, treated 12, 16, 20, 24 days 
post infection  
No Change No 
Change 
Positive ND [33, 
37] 
0.75ml of 90 day 
TCRβxδ-/- immune 
C3H SCID, treated 12, 18, 24 days post 
infection 
1/4 positive, 
decreased 
severity 
Decrease
d severity 
ND  Reduced, in ear  
 tissue only, and  
 not significantly 
1 Mice were syringe-inoculated unless otherwise stated. 
2 ND, not determined 
3 Prevalence is the mean ± SD joints with microscopic inflammation among eight joints. 
4 Severity is the mean ± SD severity of averaged scores of joints with inflammation on a scale of 0-4.
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responses, significantly higher bacterial burdens and more severe arthritis compared to 
control mice [44], indicating that CD4+ T cells likely promote arthritis resolution and 
clearance of bacteria mediated by a pathogen-specific antibody response.  A separate 
study found that adoptive transfer of CD4+ T cells into T cell-deficient mice (containing 
B cells) restored the ability of the mice to resolve carditis  in the absence of protective 
immune serum [41].  In this same study, arthritis resolution required the transfer of 
immune serum.   
 
Noncognate role for T cells in B. burgdorferi infection: iNKT cells  
Another T cell population involved in combating B. burgdorferi is the invariant natural 
killer T (iNKT) cell.  iNKT cells comprise less than 1% of mouse T cells and are unlike 
conventional T cells since they express both the αβ T cell receptor (TCR) and NK cell 
receptors [45].  They are further distinct in that they express an invariant TCRα chain 
which has a Vα14-Jα18 rearrangement in mice and a homologous human population with 
an invariant Vα24-Jα18 rearrangement [45].  Instead of recognizing peptide antigen 
presented on MHC I or II molecules like conventional T cells, iNKT cells recognize 
glycolipid antigens presented on CD1d molecules by antigen presenting cells (APCs) 
[45].  
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iNKT cells recognize microbial glycolipid antigens, such as α-galactosyl ceramide (α-
GalCer), the first known antigen for iNKT cells isolated from a marine sponge [46].  
iNKT cells act as both innate and adaptive immune cells; innate because they respond 
rapidly to antigen and adaptive because they generate an antigen-specific response.  
iNKT cells are unlike T helper (Th) cells because iNKT do not need to undergo 
differentiation and proliferation to generate cytokines and are poised to release their 
effector functions.  Upon activation iNKT cells are most well-known for secreting 
profuse amounts of IL-4 and IFN-γ, but can also produce many other cytokines such as 
IL-2, TNF, and IL-5 [45]. 
 
iNKT cells have recently been shown to directly recognize a B. burgdorferi 
diacylglycerol glycolipid, BbGL-IIc [47].  BbGL-IIc is recognized during human 
infection because human serum has a strong IgG response to this antigen, particularly in 
patients presenting with Lyme arthritis [48]. CD1d tetramers containing BbGL-IIc are 
recognized by iNKT cells and cause their activation, proliferation and release of 
cytokines such as IL-2 in vitro [47].  Additional studies have demonstrated a role for 
iNKT cells during B. burgdorferi infection.  B. burgdorferi-infected CD1d-/- mice, which 
are devoid of iNKT cells, have significantly higher numbers of spirochetes in their joints 
compared to wild type mice [49]. Jα18-/- mice, deficient in Vα14 iNKT cells present with 
more severe arthritis and carditis and are impaired at clearing B. burgdorferi from 
multiple tissue sites during infection [50, 51].  Activated iNKT cells have also been 
shown to colocalize with  CD1d-presenting macrophages in the heart leading to carditis 
11 
 
 
resolution and local production of IFN-γ which helps macrophages to phagocytose 
spirochetes [51].  
 
T-independent humoral immune response to B. burgdorferi. 
While these studies demonstrate a potential important role for cognate help for FO B cells 
provided by CD4+ T cells in Lyme disease, several observations suggest that immune 
responses that promote spirochetal clearance and/or resolution of inflammation can occur 
in the absence of robust CD4+ T cell function. Fikrig et al. [40] examined the role of 
CD4+ T cells during B. burgdorferi infection in MHC class II-deficient mice, which are 
largely deficient in CD4+ T cells. B. burgdorferi-infected MHC class II-deficient mice 
developed arthritis and carditis no more severe than that observed in wild type mice.  
Arthritis and carditis resolved in these mice, although resolution of carditis was delayed 
in MHC class II-restricted mice.  Even in the absence of canonical T cell help, passively 
transferred sera from MHC class II-deficient mice protected naïve C3H mice from 
challenge and effectively cleared spirochetes from SCID mice (Table 2).  Furthermore, 
the sera of the MHC class II-deficient mice contained B. burgdorferi-specific IgG2b, 
indicating the ability to class switch was still intact even in the absence of help from 
CD4+ T cells. 
 
CD40L-deficient mice, which are unable to provide CD40L-dependent T cell help in the 
production of antibody, showed some defects compared to wild type mice in 
immunoglobulin class switching, as all IgG isotypes of B. burgdorferi-specific were 
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decreased.  Nevertheless, CD40L-deficient mice still produced a robust B. burgdorferi-
specific IgG2b response that was only two-fold less than wild type, and these mice 
displayed no discernible difference in the development or resolution of arthritis compared 
to control mice [43]. Furthermore, transfer of CD40L-deficient immune serum prevented 
infection in SCID mice (Table 2).  Even in the absence of T-dependent humoral 
immunity, CD40L-deficient mice produced protective antibodies, further supporting the 
idea that CD40L-CD40 interactions are not required for eliciting protective antibodies 
during Lyme infections.   
 
An additional study examining the requirement for T cells in the humoral immune 
response to B. burgdorferi evaluated the role of B cells in the absence of T cells during B. 
burgdorferi infection [33].  This work by McKisic and Barthold found that while control 
mice and mice deficient in all T cells (CD4+, CD8+ and γδ+; TCRβxδ-/- mice) did not 
clear spirochetes, they exhibited equivalent levels of arthritis severity which was less 
severe than arthritis in SCID mice.  Control and TCRβxδ-/- mice were also able to resolve 
carditis while carditis remained active in SCID mice.  T cell-deficient mouse serum 
contained IgM and IgG3 B. burgdorferi-specific antibodies and protected naïve mice 
against challenge (Table 2).  At high doses, passive transfer of immune sera also induced 
arthritis and carditis remission [37]. Furthermore, TCRβxδ-/- mice also synthesized IgM 
and IgG3 antibodies which recognized DbpA.  This work demonstrated that B cells are 
capable of producing B. burgdorferi-specific antibodies in the absence of T cells, and 
more importantly, these antibodies provide protection against challenge to naïve mice. 
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B1 B cells 
The class of B cells that generate T-independent responses leading to some degree of 
protection and resolution of disease is not well characterized.  B1 cells comprise a 
subclass of T-independent B cells that are abundant in the peritoneal cavity and rare in 
the spleen and lymph nodes of mice [52, 53]. B1 cells display unique surface markers and 
are IgMhi, IgDlo, CD23-, B220lo, Mac-1+ and are further subdivided into B1a (CD5+) and 
B1b (CD5-) cells.  Another distinguishing feature of B1 cells is their ability to self-renew, 
unlike B2 cells, which continually differentiate from bone marrow-derived progenitors 
[52].  B1 cells are the major contributors to the pool of natural antibody [52, 53].   
However, there is evidence that B1 cells can increase serum antibodies in response to T 
cells, presumably in a non-cognate manner [54].  Aside from IgM, B1 cells can produce 
the full range of IgG isotypes [52, 54]. 
 
Work conducted on a related spirochete, B. hermsii, the causative agent of tick-borne 
relapsing fever, demonstrated that B1b cells are critical for resolution of the high, 
recurrent episodes of bacteremia in infected mice [55].  T cell-deficient mice, FO and 
splenic MZ B cell-deficient mice or B1a cell-deficient mice cleared B. hermsii from the 
bloodstream concomitant with an expansion of peritoneal B1b cells [55, 56], eliminating 
the possibility that T cells and FO and MZ B cells are required for clearance.  Mice 
deficient in secreted IgM suffered non-resolving high levels of bacteremia,  and un-
mutated IgM was the only antibody required for clearance of spirochetes [56].  
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Interestingly, adoptive transfer of peritoneal B1b cells from previously infected mice into 
immunocompromised RAG1-/- mice, which are unable to clear B. hermsii, allowed the 
mice to control the infection and prevented subsequent reinfection [56].  This 
demonstrated the ability of B1b cells to provide long-term immunity that was dependent 
on their ability to make pathogen-specific IgM.   
  
B1 cells have also been shown to be important for protection against Streptococcus 
pneumoniae.  Haas et al. [57] demonstrated a role for both B1a and B1b cells in 
providing immunity to S. pneumoniae.  B1a cells generated natural antibody which 
controlled bacterial numbers during the initial infection, and B1b cells produced 
protective polysaccharide-specific antibodies important for adaptive antibody responses. 
 
Interestingly, B1b cells may have a role in protection against B. burgdorferi as these cells 
were found to expand ~2-fold in B. burgdorferi-infected mice [58] 
 
Cellular basis for protection against B. burgdorferi infection 
Collectively, these investigations provide strong evidence that the B. burgdorferi-specific 
antibody response is critical for both diminishing bacterial load and in some cases, for 
resolution of pathology.  In addition, T cell help is important for a component of this 
response, but a T-independent response also appears to contribute to protection.  The 
cellular basis of this response is not understood, and given the role of B1 cells in 
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protection against B. hermsii, it is tempting to speculate that these cells also play a role in 
protection against Lyme disease.   
 
 Questions remaining to be elucidated and addressed by this study are here: 
1. What B cells are important for providing protection against tissue colonization 
and generating B. burgdorferi-specific antibodies? 
a. Do B cells require T cell help during B. burgdorferi infection? 
b. What particular antigens do B cells mount an antibody response against, 
and do T cells play a role in this response? 
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CHAPTER II 
T CELLS AID IN LIMITING PATHOGEN BURDEN AND IN ENHANCING B1 
AND B2 CELL ANTIBODY RESPONSES TO MEMBRANE GLYCOLIPID AND 
THE SURFACE LIPOPROTEIN DECORIN-BINDING PROTEIN A DURING 
BORRELIA BURGDORFERI INFECTION 
 
Summary 
Murine infection by the Lyme disease spirochete, B. burgdorferi, results in the generation 
of pathogen-specific antibody that can provide protection against Lyme disease, but the 
cells involved in this response are poorly characterized.  T cells are not required for 
generating a protective antibody response to B. burgdorferi infection, but their exact role 
in providing protection against tissue colonization had not been previously determined.  
We found that TCRβxδ-/- mice were susceptible to high pathogen loads and decreased 
antibody titers, but inhibition of CD40L-dependent interactions resulted in partial 
protection suggesting that a portion of the help provided by T cells was not dependent on 
CD40L-CD40 interactions between T and B cells.  RAG1-/- mice reconstituted with either 
un-fractionated or B1-enriched peritoneal cells from previously infected mice generated 
B. burgdorferi-specific antibody, and upon spirochetal challenge suffered significantly 
lower levels of pathogen load in the joint and heart.  Peritoneal cells from previously 
infected TCRβxδ-/- mice or B2-enriched or B1-purified peritoneal cells conferred little to 
only moderate protection, suggesting T cells play an important role in protection against 
spirochetal infection the joint. Consistent with this, T cells from previously infected 
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donor mice, when transferred with B1 or B2 cells into RAG1-/- mice, generated increased 
antibody titers and were capable of diminishing bacterial burden in the joint and heart.  A 
previously identified class of protective antibody is directed against the spirochetal 
surface lipoprotein DbpA, and we found that DbpA is a prominent protein antigen 
recognized by RAG1-/- mice reconstituted with B1-enriched peritoneal cells.  
Additionally, we found that mice reconstituted with B1 cells also make antibody directed 
towards the spirochetal glycolipid antigen, BbGL-IIc, which is recognized by Vα14iNKT 
cells.  Consistent with the idea that T cells are important in providing protection against 
spirochetal infection, RAG1-/- mice reconstituted with B1 and T cells generated a more 
robust response against DbpA and BbGL-IIc.  These results support the hypothesis that T 
cells act with B1 cells in a CD40L-independent manner to promote the production of 
antibodies that play an important role in protection of the joint from spirochetal infection. 
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Introduction 
Lyme disease is the most common vector-borne illness in the United States.  It is a 
complex, multi-system infection that is especially dependent on the host’s ability to 
mount an effective humoral immune response to the invading pathogen, B. burgdorferi .  
The bacteria are transmitted to its host by the bite of a hard-bodied tick, Ixodes 
scapularis, where it causes the first of three stages of disease stages [4, 5].  Upon entry 
into the host, the bacteria cause a localized skin infection, typically presenting as 
erythema migrans, and accompanied by flu-like symptoms.  The second stage of disease 
occurs when the bacteria disseminate to distant sites causing joint and muscle pain, 
cardiac and neurological problems, and flu-like symptoms.  The third stage, persistent 
infection, can occur weeks, months and even years after dissemination and involves 
severe joint pain and swelling and additional cardiac and neurological involvements. 
 
The mouse model is a useful tool for studying Lyme disease since many features of 
human Lyme disease occur in the mouse [7].  Skin colonization occurs at the site of 
injection, and this is followed shortly by dissemination and development of arthritis and 
carditis.  Mice can also become chronically infected in the absence of apparent disease 
[8].   
 
An adaptive immune response is important for diminishing bacterial load and for disease 
resolution because SCID mice are unable to clear the bacteria [12].  Adoptive transfer of 
T cells from B. burgdorferi-immune mice did not protect naïve mice from challenge [14] 
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indicating that T cells alone were not sufficient to prevent infection.  Similarly, B cell-
deficient mice suffered from severe arthritis and carditis compared to control mice [13].  
Thus, the humoral immune response plays a particularly crucial role. 
 
One of the best-characterized B. burgdorferi outer membrane protein antigens is decorin 
binding protein A (DbpA).  Importantly, antibodies to DbpA are found in patients with 
late-stage Lyme disease [32] and mice seroconvert by 2 weeks post-infection [33].  
Immunization with DbpA or passive transfer of DbpA antiserum protects mice from 
subsequent challenge with B. burgdorferi [34-37].   
 
A prominent non-protein antigenic target is an outer membrane glycolipid, BbGL-IIc, 
which is recognized by iNKT cells [47].  B. burgdorferi-infected mice that are deficient 
in iNKT cells suffer from chronic arthritis and decreased clearance of spirochetes from 
tissues [50].  BbGL-IIc is recognized during human infection because human serum has a 
strong IgG response to this antigen [48].    
 
Because antibody is critical for generating protection against B. burgdorferi, the role of 
CD4+ T cells in Lyme disease has been extensively studied.  CD4+ T cells have been 
shown to be important for generating antibodies, decreasing bacterial burdens and 
reducing arthritis and carditis severity in mice [41, 44]. 
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Conversely, several studies have demonstrated that T cells are not required for protection.  
Mice deficient in CD4+ T cells due to a deficiency in MHC class II did not develop 
severe disease and generated protective antibodies [40].  CD40 ligand-deficient mice, 
which are unable to provide help to B cells in the production of antibody, developed B. 
burgdorferi-specific antibodies that prevented infection in SCID mice [43]. Similarly, 
mice devoid of all T cells still generate protective antibodies, including antibodies to 
DbpA [33, 37]. 
 
The class of B cells that generate T-independent responses leading to some degree of 
protection and resolution of disease is not well characterized.  B1 cells comprise a 
subclass of T-independent B cells that are abundant in the peritoneal cavity and rare in 
the spleen and lymph nodes of mice [52, 53].   B1 cells are the major contributors to the 
pool of natural antibody [52, 53] and typically respond to T-independent antigens unlike 
conventional B2 cells, which normally require T cell help.  However, there is evidence 
that B1 cells can increase serum antibodies in response to T cells, presumably in a non-
cognate manner [54].  Aside from IgM, B1 cells can produce the full range of IgG 
isotypes [52, 54].   
 
Work conducted on a related spirochete, B. hermsii, the causative agent of tick-borne 
relapsing fever, demonstrated that B1b cells are critical for resolution of the high, 
recurrent episodes of bacteremia in infected mice [55].  B1 cells have also been shown to 
be important for Streptococcus pneumoniae.  Haas et al. [57] demonstrated a role for both 
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B1a and B1b cells in providing immunity to S. pneumoniae where B1a cells generated 
natural antibody which controlled bacterial numbers during the initial infection, and B1b 
cells produced protective polysaccharide-specific antibodies important for adaptive 
antibody responses. 
 
Interestingly, B1b cells may have a role in protection against B. burgdorferi as these cells 
were found to expand ~2-fold in B. burgdorferi-infected mice [58] 
 
Collectively, these investigations provide strong evidence that the B. burgdorferi-specific 
antibody response is critical for both diminishing bacterial load and in some cases, for 
resolution of pathology.  In addition, T cell help is important for a component of this 
response, but a T-independent response also appears to contribute to protection.  The 
cellular basis of this response is not understood, and given the role of B1 cells in 
protection against B. hermsii , it is tempting to speculate that these cells also play a role 
in protection against Lyme disease.   
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Experimental Procedures 
Borrelia burgdorferi 
All B. burgdorferi strains were cultured at 33° in BSK-II medium supplemented with 6% 
rabbit serum (Sigma-Aldrich, St. Louis, MO). Infectious B. burgdorferi strain N40 clone 
D10/E9 [59] was used for all murine infections.  High-passage strain B314 [60] was used 
for western blots as well as B314/pDbpA, B314/pDbpB, B314/pDbpAB and were 
constructed and grown under selective pressure as previously described [27]. Details 
about the generation of dbpA-dbpB deletion mutants in the low passage, infectious B. 
burgdorferi N40 strain D10/E9 clone will be described elsewhere. Briefly, strain N40 
was transformed with pNP3 [61] which encodes the N40 dbpBA operon in which the 
bulk of the dbpB-dbpA  coding region is replaced by an aacc1 gene encoding resistance 
to gentamycinR, modified to express significantly in the spirochetes. Several gentamicin-
resistant colonies were harvested and replacement of dbpB-dbpA with the aacC1 cassette 
was confirmed by PCR. The absence of DbpA and DbpB proteins was confirmed by 
immunoblotting with anti-DbpA and anti-DbpB antiserum. The presence of endogenous 
plasmids in each of the clones was determined by PCR, similar to as previously described 
[62] (data not shown).  B. burgdorferi mutant NP4.1 was selected for further work. 
Mice and Infections 
Mice were maintained in a specific pathogen-free facility of the Department of Animal 
Medicine at the University of Massachusetts Medical School (UMMS).  Normal 10-12 
week old C57BL/6J  and 129/SvJ mice were purchased from The Jackson Laboratory 
(Bar Harbor, ME) or bred.  sIgM-/-, C57BL/6J-TCR-βtm1 MomTCR-δtm1 Mom (TCRβxδ-/-) 
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and C57BL/6J-RAG1tm1 Mom (RAG1-/-) were bred.  B. burgdorferi were thawed from 
frozen stocks, cultured to mid-log phase and counted by dark-field microscopy prior to 
injection.  Mice were injected intradermally (i.d.) with 2x104 spirochetes in 50µl of BSK-
II medium along the midline above the hindquarter [37]. For reconstitution experiments 
mice were treated with ceftriaxone (Sigma-Aldrich, St. Louis, MO) at 16mg/kg by 
intraperitoneal (i.p.) injection 5 days prior to harvesting peritoneal cells for transfer.  
Mice treated with the anti-CD40 ligand (CD40L) antibody MR-1 (generously provided 
by Dale Greiner) were injected i.p. with 0.5mg of antibody every four days throughout 
the study beginning 7 days prior to infection.   
 
Flow Cytometry 
Peritoneal cavity cells were collected from individual mice and counted by light 
microscopy on a hemocytometer.  Cell numbers were adjusted to 2.5x107/ml in staining 
medium (deficient RPMI 1640, Hepes: 10mM, Final pH = 7.2 [Irvine Scientific, Santa 
Ana, CA] supplemented with 3% new calf serum, 0.02% Sodium Azide and 1mM 
EDTA).  Fc receptors were blocked with 2.4G2 antibody (Becton Dickinson, Franklin 
Lakes, NJ) at 1µg per 106 cells, followed by incubation of 25µl of cells with antibodies in 
a microtiter plate.  The antibodies included: anti-IgM-FITC (clone: 1B481) (Southern 
Biotech Birmingham, AL), anti-IgD-Biotin (clone: 11-26) (eBioscience, San Diego, CA) 
or anti-CD23-Biotin (clone: B3B4) (eBioscience), anti-CD5-PE (clone: 53-7.3) 
(eBioscience), anti-Mac1-APC (clone: M1/70) (eBioscience) and anti-CD23-PE (clone: 
B3B4) (eBioscience).  Streptavidin-PE-Cy5 was purchased from PharMingen (San 
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Diego, CA).  Cells were washed twice in staining medium after staining and resuspended 
in staining medium containing 1µg/ml of propidium iodide to exclude dead cells.  Cells 
were transferred to polystyrene FACS tubes and run on a FACScalibur (Becton 
Dickinson) where data was collected using CELLQuest software (Becton Dickinson).  
Data was analyzed using FlowJo software (Treestar, Ashland, OR). Cells were gated to 
define lymphocytes by forward (FSC) and side scatter (SSC), and distinct lymphocyte 
populations were identified as follows: T cells (IgM-, CD5+), B2 cells (IgM+, Mac1- or 
CD23+), B1a cells (IgM+,Mac1+, CD5+) and B1b cells (IgM+,Mac1+, CD5-).  Gates for 
each cell population were defined by running appropriately stained control cells in 
parallel.      
 
Reconstitution of RAG1-/- mice with Peritoneal Cells 
RAG1-/- mice were reconstituted with either un-fractionated, enriched or purified 
peritoneal cavity cells from naïve C57BL/6 (WT) or TCRβxδ-/- mice, or mice previously 
infected for 4 weeks with B. burgdorferi. when indicated. Unfractionated peritoneal cells 
were harvested from as previously described [56]. In brief, peritoneal cavity cells were 
collected, pooled and live cells were enumerated by light microscopy on a 
hemocytometer by Trypan Blue exclusion.    Cells were washed 3 times in Delbecco’s 
Phosphate Buffered Saline (PBS [Invitrogen, Carlsbad, CA]) and resuspended in PBS in 
appropriate cell density dilutions so that 250µl of cells were injected by i.p. into each 
mouse.  RAG1-/- mice receiving un-fractionated peritoneal cells were either reconstituted 
at a ratio of 2 donor mice to 1 recipient mouse  or with cells normalized to 2x105 B1b 
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cells per mouse as previously described for reconstitution experiments in B. hermsii 
(Table 3, [56]). These mice, reconstituted with un-fractionated peritoneal cells, as well as 
unreconstituted RAG1-/- mice, were routinely included in all reconstitution experiments. 
 
Reconstitution of RAG1-/- mice with MACS-enriched B2 or B2 and T cells 
Peritoneal cells were harvested from infected mice, adjusted to 6 x107/ml in staining 
medium and blocked for nonspecific binding to Fc receptors as described above. To 
prepare MACS-enriched B2 cells, pooled cells were incubated with anti-Mac-1-biotin 
(clone: M1/70) (1:200), anti-CD5-biotin (clone: 53-7.3) (eBioscience) (1:800), and anti-
CD43 (clone: S7) (BD Pharmingen) (1:100) to deplete B1 and T cells.  To prepare 
MACS-enriched B2 and T cells, pooled cells were incubated with anti-CD9-biotin (clone: 
KMC8) (BD Pharmingen) (1:25) and anti-Mac-1-biotin (1:200) to deplete B1 cells.  After 
washing, cells were resuspended at 1x107 cells per 90µl in buffer (PBS, ph=7.2 
containing 2mM EDTA) and 10µl of streptavidin-microbeads (Miltenyi Biotec) were 
added for every 1x107 cells.  Flow-through cells were collected and cell purity and 
viability was determined by flow cytometry.   Enrichment of B2 cells after depletion of T 
and B1 cells generated about 3-fold more B2 cells compared to un-fractionated peritoneal 
cells (Figure 1) while enrichment of B2 and T cells after depletion of B1 cells was more 
modest (B2 cells ~1.5-fold enrichment, T cells ~1.3-fold enrichment compared to un-
fractionated cells).   Recovered cells were enumerated for live cells by microscopy, 
washed, and RAG1-/- mice were reconstituted with ~1x105 B2 cells or 1x105 B2 and 
6.5x104 T cells (Table 4). 
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a RAG1-/- mice were reconstituted with un-fractionated  convalescent peritoneal cells from C57Bl/6 
(WT) or T cell-deficient (TCRβxδ-/-) mice.  The number of each lymphocyte population transferred 
into each mouse was calculated by multiplying the percent of each cell population, determined by 
flow cytometry (as described in Methods), by the total number of cells transferred into each mouse.   
 
b Peritoneal cells were recovered four weeks after infection with B. burgdorferi and stained for flow 
cytometric analysis.  Cell numbers were calculated by multiplying the percent of each lymphocyte 
population, determined by flow cytometry, by the total number of cells recovered from the peritoneal 
cavity of each mouse.  Values presented are the mean from each group ± the standard deviation. 
 
c nd, not determined. 
 
 
 
Table 3. Analysis of lymphocyte populations at the time of reconstitution of RAG1 -/-
mice and recovery 4 weeks post B. burgdorferi infection.
Un-fractionated pertitoneal cells from 
wild-type or TCRβxδ-/- mice
 
B2 T B1a B1b
Donor Cells (IgM+, Mac1-) (IgM-, CD5+) (IgM+, Mac1+, CD5+) (IgM+, Mac1+, CD5-)
Total cells injected 
Reconstitutiona per mouse
WT 2,500,000 170,000 160,000 220,000 460,000
TCRβxδ-/- 2,260,000 110,000 ndc 230,000 320,000
Recoveryb Mice per group
WT n=5 8,700 ± 6,800 142,000 ± 47,900 132,000 ± 57,200 329,000 ± 122,000
TCRβxδ-/- n=10 7,520 ± 4,650 nd 197,000 ± 92,200 165,000 ± 63,400
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Figure 1.  Purity of MACS-enriched B2 and B2 and T lymphocytes.  Peritoneal cells were recovered 
from C57Bl/6 mice that were previously infected with B. burgdorferi for 4 weeks.  As a control, one 
portion of the recovered cells remained un-fractionated (WT).  To generate a pool of lymphocytes enriched 
for B2 cells, the peritoneal cells were stained with antibodies to deplete B1 (anti-CD5, anti-Mac1) and T 
(anti-CD5, anti-CD43) cells.  To generate a pool of lymphocytes enriched for B2 and T cells, peritoneal 
cells were stained with antibodies to deplete B1 (anti-CD9, anti-Mac1) cells.  After MACS-enrichment, the 
negatively selected cell preparations enriched for B2 cells were stained with anti-CD23-PE to detect the 
number of B2 cells, and the negatively selected cell preparations enriched for B2 and T cells were stained 
with anti-IgM-FITC and anti-CD5-PE (to detect T cells) or anti-CD23-PE (to detect B2 cells).  B1 and T 
cell depletions were not determined for this experiment.  B2 cells were identified as CD23+ lymphocytes 
(bottom panels) and were 3-fold higher compared to un-fractionated cells (66% compared to 22%).  B2 and 
T cell enriched lymphocytes had ~1.6-fold increase in B2 cells.  To identify T cells, lymphocytes were 
distinguished as IgM- and CD5+ (3rd row).  Enriched T cells (B2+T) were ~1.3-fold higher in the 
lymphocyte compartment compared to un-fractionated cells (20% compared to 15%). ND, not determined. 
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a RAG1-/- mice were reconstituted with un-fractionated  convalescent peritoneal cells (WT) or MACS-
enriched populations of peritoneal cells comprising convalescent B2 cells alone (B2) or convalescent B2 
and T cells (B2+T). The number of each lymphocyte population transferred into each mouse was calculated 
by multiplying the percent of each cell population, determined by flow cytometry (as described in 
Methods), by the total number of cells transferred into each mouse.   
 
b Peritoneal cells were recovered four weeks after infection with B. burgdorferi and stained for flow 
cytometric analysis.  Cell numbers were calculated by multiplying the percent of each lymphocyte 
population, determined by flow cytometry, by the total number of cells recovered from the peritoneal cavity 
of each mouse.  Values presented are the mean from each group ± the standard deviation. 
 
c nd, not determined. 
 
 
 
 
 
 
 
 
 
 
MACS-enriched B2 and B2+T lymphocytes 
Table 4.  Analysis of lymphocyte populations at the time of reconstitution of RAG1 -/- 
mice and recovery 4 weeks post B. burgdorferi infection. 
 
B2 T B1a B1b
Donor Cells (CD23+) (IgM-, CD5+) (IgM+, Mac1+, CD5+) (IgM+, Mac1+, CD5-)
Total cells injected 
Reconstitutiona per mouse
WT 2,580,645 180,645 160,000 610,000 440,000
B2 157,264 92,000 ndc nd nd
B2+T 500,000 140,000 79,000 nd nd
Recoveryb Mice per group
WT n=5 17,000 ± 6,000 110,000 ± 100,000 56,000 ± 21,000 47,000 ± 28,000
B2 n=5 6,700 ± 1,700 7,700 ± 14,000 6,900 ± 2,600 18,000 ± 6,200
B2+T n=5 14,000 ± 4,200 99,000 ± 53,000 31,000 ± 23,000 39,000 ± 28,000
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Reconstitution of RAG1-/- mice with MACS-enriched B1b Cells 
Peritoneal cells were harvested from infected mice, adjusted to 6 x107/ml in staining 
medium and blocked for nonspecific binding to Fc receptors as described above. B1b 
cells were enriched by depleting B2, B1a and T cells by magnetic-activated cell-sorting 
(MACS) on an AutoMACS (Miltenyi Biotec, Auburn, CA).  Briefly, cells were stained 
with anti-CD23-PE to deplete B2 cells and anti-CD5-PE to deplete T and B1a cells at 
1:200 in staining medium.  After washing, cells were resuspended at 1x107 cells per 
120µl in buffer (PBS, ph=7.2 containing 0.5% BSA and 2mM EDTA) and 30µl of anti-
PE-microbeads (Miltenyi Biotec) were added for every 1.5x107 cells.  B1b cells were 
collected as flow through and cell depletions were determined by flow cytometry (B2 
>98%, T >98%, B1a>95%) (Figure 2).  Recovered cells were enumerated for live cells 
by microscopy, washed, and RAG1-/- mice were reconstituted with ~2x105 B1b cells 
(Table 5).   
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a RAG1-/- mice were reconstituted with MACS-enriched B1b cells from naïve (Naïve B1b) or 
convalescent (Conv. B1b) mice. The number of each lymphocyte population transferred into each mouse 
was calculated by multiplying the percent of each cell population, determined by flow cytometry (as 
described in Methods), by the total number of cells transferred into each mouse.   
 
b Peritoneal cells were recovered four weeks after infection with B. burgdorferi and stained for flow 
cytometric analysis.  Cell numbers were calculated by multiplying the percent of each lymphocyte 
population, determined by flow cytometry, by the total number of cells recovered from the peritoneal cavity 
of each mouse.  Values presented are the mean from each group ± the standard deviation. 
 
 
 
 
 
 
Table 5.  Analysis of lymphocyte populations at the time of reconstitution of RAG1 -
/- mice and recovery 4 weeks post B. burgdorferi infection. 
MACS-enriched B1b 
 
B2 T B1a B1b
Donor Cells (IgM+, Mac1-) (IgM-, CD5+) (IgM+, Mac1+, CD5+) (IgM+, Mac1+, CD5-)
Total cells injected 
Reconstitutiona per mouse
Naïve B1b 925,000 1,800 925 14,800 216,450
Conv. B1b 968,000 2,900 1,938 14,600 210,218
Recoveryb Mice per group
Naïve B1b n=5 11,000 ± 8,600 1,600 ± 5,000 45,000 ± 14,000 67,000 ± 22,000
Conv. B1b n=5 990 ± 250 1,900 ± 730 41,000 ± 17,000 54,000 ± 21,000
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Figure 2.   Purity of MACS-enriched B1b lymphocytes.  Peritoneal cells were recovered from C57Bl/6 
mice that were uninfected (naïve) or previously infected with B. burgdorferi for 4 weeks (convalescent).  
To generate a pool of lymphocytes enriched for B1b cells, the peritoneal cells were either un-fractionated 
or stained with antibodies to deplete B2 (anti-CD23), B1a (anti-CD5) and T (anti-CD5) cells.  After 
MACS-enrichment, the negatively selected cell preparations (enriched for B1b cells) were stained with 
anti-IgM-FITC, anti-CD5-PE and anti-Mac1-APC to determine the percent of B1b cell enrichment and to 
confirm the depletion of B2, B1a and T cells.  B1 cells were identified as IgM+, Mac1+ (top panels) and 
further gated for CD5 expression to distinguish B1a and B1b cells (2nd row of panels).  B1a cells (CD5+) 
were depleted ~4.7-fold (4% compared to 19% in the un-fractionated cell preparation), and B1b cells (CD5-
) were enriched ~2.5-fold (52-55% compared to 21%).  To determine the efficiency of T and B cell 
depletions, lymphocytes were separated by IgM expression.  T cells (3rd row of panels) were distinguished 
as IgM- and CD5+, and B cells (bottom row of panels) were IgM+, and Mac1-.  T cells were depleted to 
<1% of lymphocytes while un-fractionated cells contained ~9% T cells in the lymphocyte pool.  B2 cells 
were also depleted to <1% of lymphocytes, and un-fractionated lymphocytes contained ~5% of B2 cells.  
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Reconstitution of RAG1-/- mice with FACS-purified B1a or B1b cells 
Peritoneal cells were harvested from infected mice, adjusted to 1x107/ml in staining 
medium and blocked for nonspecific binding to Fc receptors as described above. Pooled 
peritoneal cells were incubated with anti-IgM-FITC  (1:100), anti-Mac-1-APC (1:100) 
and anti-CD5-PE (1:100).  B1b cells, selected by fluorescence-activated cell-sorting 
(FACS) in a FACSVantage SE (Becton Dickinson), characterized as IgM positive, Mac-1 
positive and CD5 negative, were found to be 95% pure (Figure 3).  Recovered cells were 
enumerated for live cells by microscopy, washed, and RAG1-/- mice were reconstituted 
with ~1.5x105 B1b cells (Table 6).   
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a RAG1-/- mice were reconstituted with FACS-purified, convalescent B1b cells. The number of each 
lymphocyte population transferred into each mouse was calculated by multiplying the percent of each cell 
population, determined by flow cytometry (as described in Methods), by the total number of cells 
transferred into each mouse.   
 
b Peritoneal cells were recovered four weeks after infection with B. burgdorferi and stained for flow 
cytometric analysis.  Cell numbers were calculated by multiplying the percent of each lymphocyte 
population, determined by flow cytometry, by the total number of cells recovered from the peritoneal cavity 
of each mouse.  Values presented are the mean from each group ± the standard deviation. 
 
c nd, not determined. 
 
 
FACS-purified B1b Cells
 
B2 T B1a B1b
Donor Cells (IgM+, Mac1-) (IgM-, CD5+) (IgM+, Mac1+, CD5+) (IgM+, Mac1+, CD5-)
Total cells injected 
Reconstitutiona per mouse
Conv B1b 166,000 ndc nd 2,200 150,000
Recoveryb Mice per group
Conb B1b n=5 67 ± 107 1,529 ± 953 1,253 ± 494 38,387 ± 16,877
Table 6.  Analysis of lymphocyte populations at the time of reconstitution of RAG1 -/- 
mice and recovery 4 weeks post B. burgdorferi infection. 
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Figure 3.  Purity of FACS-purified B1b lymphocytes.  Peritoneal cells were recovered from C57Bl/6 
mice that previously infected with B. burgdorferi for 4 weeks.  To generate a purified population of B1b 
cells, the peritoneal cells were stained with anti-IgM-FITC, anti-Mac1-APC and anti-CD5-PE to deplete 
B2, B1a and T cells.  After sorting, 96% of all the cells were lymphocytes.  Of those, 97% were B1 cells 
and 98% of B1 cells (or 95% of all lymphocytes) were B1b cells (IgM+, Mac1+, CD5-).  B1a cells 
comprised <2% of the lymphocytes. 
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Reconstitution of RAG1-/- mice with MACS-enriched B1 cells, naïve T and B1 cells 
or convalescent T and B1 cellsPeritoneal cells were harvested from infected mice, 
adjusted to 6 x107/ml in staining medium and blocked for nonspecific binding to Fc 
receptors as described above. To prepare MACS-enriched B1 cells, pooled cells were 
incubated with anti-IgD-biotin (1:200), anti-CD23-biotin (1:100), anti-CD4 (clone: 
L3T4) (eBioscience) (1:400) and anti-CD8-biotin (clone: 53-6.7) (eBioscience) (1:800) to 
deplete B2 and T cells.  To prepare MACS-enriched B1 and convalescent T cells, pooled 
cells were incubated with anti-CD23-biotin (1:100) and anti-IgD-biotin (1:200) to deplete 
B2 cells.  To prepare B1 cells with naïve T cells, we first depleted B2 and T cells as 
described above and then added naïve T cells depleted of B1 and B2 cells.  We depleted 
B1 and B2 cells with anti-IgD-biotin (1:200), anti-CD23-biotin (1:100), anti-CD9 (1:25) 
and anti-Mac-1 (1:200).  After washing, cells were resuspended at 1x107 cells per 90µl in 
buffer (PBS, ph=7.2 containing 2mM EDTA) and 10µl of streptavidin-microbeads 
(Miltenyi Biotec) were added for every 1x107 cells.  Flow-through cells were collected 
and cell purity and viability was determined by flow cytometry.  MACS-enriched B1 
cells were depleted of B2 (>97%) and T (>97%) cells, B1 and T cells were depleted of 
B2 cells (>98%) and naïve T cells were depleted of B2 cells (>94%) while B1 cells were 
decreased ~2.5 fold compared to un-fractionated peritoneal cells (Figure 4).  The largest 
portion of B1 cells in the naïve T cell pool was B1a cells as B1b cells were depleted to 
>93%.  Recovered cells were enumerated for live cells by microscopy, washed, and 
RAG1-/- mice were reconstituted with ~1-2x105 B1 cells and/or ~1x105 naïve or 
convalescent T cells (Tables 7 and 8).  
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Figure 4.  Purity of MACS-enriched B1, B1 and naïve T and B1 and convalescent T lymphocytes.  
Peritoneal cells were recovered from C57Bl/6 mice that were uninfected (naïve) or previously infected with 
B. burgdorferi for 4 weeks.  As a control, one portion of the recovered cells remained un-fractionated 
(WT).   To generate a pool of lymphocytes enriched for B1 cells, the peritoneal cells were stained with 
antibodies to deplete B2 (anti-CD23, anti-IgD) and T (anti-CD4, anti-CD8) cells.  A population enriched 
for B1 and T cells (B1+T) was generated by depleting B2 (anti-CD23, anti-IgD) cells and a population of 
enriched naïve T cells was generated by depleting B2 (anti-IgD, anti-CD23) and B1 (anti-CD9, anti-Mac1) 
cells.  After MACS-enrichment, the negatively selected cell preparations enriched for B1, B1 and T or 
naïve T cells were stained with anti-IgM-FITC, anti-CD5-PE and anti-Mac1-APC to determine the 
percentages of cell enrichments and to confirm cell depletions.  B1 cells were identified as IgM+, Mac1+ 
(top panels) and further gated for CD5 expression to distinguish B1a and B1b cells (2nd row of panels).  
Percentages (relative to total lymphocytes) of B1a (CD5+) and B1b (CD5-) cells in the MACS-enriched B1 
lymphocyte population were similar to those of un-fractionated cells (B1 cells: 25% B1a, 32% B1b, un-
fractionated: 30% B1a, 32%B1b).  MACS-enriched B1 and T cells had about half the amount of B1a cells 
(17%) and the B1b cell population remained largely unchanged (28%).  MACS-enriched naïve T cells had 
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a 1.5-fold decrease in B1a cells (19% compared to 30%) and an ~5-fold decrease in B1b cells (6% 
compared to 32%).  T cells (3rd row of panels) were identified by being IgM-, CD5+.  Enriched B1 cells 
were depleted to 5% of IgM- cells (or 2% of all lymphocytes) compared to un-fractionated cells where 49% 
of IgM- cells comprised T cells (and 8% of lymphocytes were T cells).  Enriched B1 and T cells showed a 
2.2-fold increase in the percent of T cells (18% compared to 8%), and enriched naïve T cells had a 6.5-fold 
increase in the percent of T cells (52% compared to 8%).  B2 cells (bottom panels) were identified by being 
IgM+ and Mac1-.  Enriched B1 cells had a 5-fold decrease (2% compared to 10% of un-fractionated cells, 
relative to the lymphocyte population).  Enriched B1 and T cells showed a 10-fold decrease in B2 cells (1% 
compared to 10%), and enriched naïve T cells had a 2-fold decrease in B2 cells (5% compared to 10%).   
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a RAG1-/- mice were reconstituted with un-fractionated  convalescent peritoneal cells (WT) or MACS-
enriched populations of peritoneal cells comprising convalescent B1 cells alone (B1), convalescent B1 and 
naïve T cells (B1+T(N)) or convalescent B1 and convalescent T cells (B1+T(C)). The number of each 
lymphocyte population transferred into each mouse was calculated by multiplying the percent of each cell 
population, determined by flow cytometry (as described in Methods), by the total number of cells 
transferred into each mouse.   
 
b Peritoneal cells were recovered four weeks after infection with B. burgdorferi and stained for flow 
cytometric analysis.  Cell numbers were calculated by multiplying the percent of each lymphocyte 
population, determined by flow cytometry, by the total number of cells recovered from the peritoneal cavity 
of each mouse.  Values presented are the mean from each group ± the standard deviation. 
 
 
 
 
 
 
 
 
 
Table 7.  Analysis of lymphocyte populations at the time of reconstitution of RAG1 
-/- mice and recovery 4 weeks post B. burgdorferi infection. 
MACS-enriched B1, B1 and naïve T or  
B1 and convalescent T lymphocytes 
 
B2 T B1a B1b
Donor Cells (IgM+, Mac1-) (IgM-, CD5+) (IgM+, Mac1+, CD5+) (IgM+, Mac1+, CD5-)
Total cells injected 
Reconstitutiona per mouse
WT 1,115,000 49,450 40,250 150,650 159,850
B1 2,842,000 14,210 14,210 181,888 233,044
B1+T(N) 3,069,777 21,954 101,220 212,865 242,382
B1+T(C) 2,000,000 8,000 122,000 112,000 188,000
Recoveryb Mice per group
WT n=5 75,000 ± 31,000 170,000 ± 71,000 430,000 ± 220,000 750,000 ± 240,000
B1 n=5 8,800 ± 4,000 21,000 ± 25,000 60,000 ± 39,000 49,000 ± 32,000
B1+T(N) n=5 8,300 ± 2,600 130,000 ± 56,000 87,000 ± 42,000 36,0000 ± 18,000
B1+T(C) n=5 10,000 ± 4,600 180,000 ± 92,000 88,000 ± 40,000 89,0000 ± 43,000
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Figure 5.  Purity of MACS-enriched B1 and B1 with T lymphocytes.  Peritoneal cells were recovered 
from C57Bl/6 mice that were previously infected with B. burgdorferi for 4 weeks.  As a control, one 
portion of the recovered cells remained un-fractionated (WT).   To generate a pool of lymphocytes enriched 
for B1 cells, the peritoneal cells were stained with antibodies to deplete B2 (anti-CD23, anti-IgD) and T 
(anti-CD4, anti-CD8) cells.  A population enriched for B1 and T cells (B1+T) was generated by depleting 
B2 (anti-CD23, anti-IgD) cells. After MACS-enrichment, the negatively selected cell preparations enriched 
for B1 or B1 and T were stained with anti-IgM-FITC, anti-CD5-PE and anti-Mac1-APC to determine the 
percentages of cell enrichments and to confirm cell depletions.  B1 cells were identified as IgM+, Mac1+ 
(top panels) and further gated for CD5 expression to distinguish B1a and B1b cells (2nd row of panels).   
 
Percentages (relative to total lymphocytes) of B1a (CD5+) and B1b (CD5-) cells in the MACS-enriched B1 
lymphocyte population were compared to those of un-fractionated cells.  The percent of B1b cells remained 
similar while B1a cells were down ~2-fold in the B1-enriched group (B1 cells: 16% B1a, 29% B1b, un-
fractionated: 31% B1a, 30%B1b).  MACS-enriched B1 and T cells also had ~2-fold reduction in B1a cells 
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(16%) and the B1b cell population remained largely unchanged (24%).  T cells (3rd row of panels) were 
identified by being IgM-, CD5+.  T cells in the enriched B1 cell group were depleted to 3% of IgM- cells (or 
2% of all lymphocytes) compared to un-fractionated cells where 58% of IgM- cells comprised T cells (and 
15% of lymphocytes were T cells).  T cells in the enriched B1 and T cell group were similar to those in the 
un-fractionated cell group (17% compared to 15% of lymphocytes were T cells).  B2 cells (bottom panels) 
were identified as being IgM+ and Mac1-. Enriched B1 and enriched B1 and T cells had 0.003% and 
0.0006% B2 cells, respectively, in their lymphocyte populations compared to un-fractionated cells which 
had 6% B2 cells. 
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a RAG1-/- mice were reconstituted with un-fractionated  convalescent peritoneal cells (WT) or MACS-
enriched populations of peritoneal cells comprising convalescent B1 cells alone (B1) or convalescent B1 
and T cells (B1+T). The number of each lymphocyte population transferred into each mouse was calculated 
by multiplying the percent of each cell population, determined by flow cytometry (as described in 
Methods), by the total number of cells transferred into each mouse.   
 
b Peritoneal cells were recovered four weeks after infection with B. burgdorferi and stained for flow 
cytometric analysis.  Cell numbers were calculated by multiplying the percent of each lymphocyte 
population, determined by flow cytometry, by the total number of cells recovered from the peritoneal cavity 
of each mouse.  Values presented are the mean from each group ± the standard deviation. 
 
 
 
 
 
 
 
 
 
 
 
Table 8.  Analysis of lymphocyte populations at the time of reconstitution of RAG1 
-/- mice and recovery 4 weeks post B. burgdorferi infection. 
MACS-enriched B1 and B1 and T lymphocytes 
 
B2 T B1a B1b
Donor Cells (IgM+, Mac1-) (IgM-, CD5+) (IgM+, Mac1+, CD5+) (IgM+, Mac1+, CD5-)
Total cells injected 
Reconstitutiona per mouse
WT 2,580,645 180,645 160,000 610,000 440,000
B1  1,430,000 10 7,200 54,000 120,000
B1+T 1,150,000 18 59,000 51,000 98,000
Recoveryb Mice per group
WT n=5 17,000 ± 6,000 110,000 ± 100,000 56,000 ± 21,000 47,000 ± 28,000
B1 n=5 1,300 ± 650 2,300 ± 2,300 11,000 ± 6,500 9,100 ± 5,900
B1+T n=5 8,700 ± 4,200 170,000 ± 140,000 34,000 ± 22,000 38,000 ± 24,000
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Quantitative analysis of B. burgdorferi in mouse tissues 
At 4 weeks post infection, tissues were collected.   For three of the experiments presented 
in this study (un-fractionated peritoneal cells, MACS-enriched B1b cells, and FACS-
purified B1b cells) the whole heart and both knee joints were removed and processed for 
qPCR.  For the remaining experiments, we attempted to analyze arthritis and carditis in 
the same mice used for qPCR, so the samples were split.  The right knee joint was 
processed for qPCR and the left was preserved for histopathological analysis.  The heart 
was bisected in a sagittal plane and further divided between the apex and base, as 
previously described [37]  The right side was processed for qPCR and the left was 
preserved for histopathological analysis. Immediately upon harvesting and sectioning, 
tissues were frozen at -20°.  At a later time, tissues were thawed and weighed and, DNA 
was extracted using DNeasy tissue kits according to the manufacturer’s instructions for 
tissue (QIAGEN, Valencia, CA).  DNA concentration was measured on a NanoDrop 
1000 (Thermo Fisher Scientific, Wilmington, DE) and diluted to 50ng/ul.  Up to 200ng of 
total DNA were used for each reaction.   
 
PCR was performed in a DNA Engine Opticon™ 2 (Bio-Rad, Hercules, CA) cycler in a 
10µl volume.  Samples were loaded into Multiplate low-profile 96-well plates (Bio-Rad, 
Hercules, CA) which contained dilution buffer with 3 mM MgCl2 (Idaho Technology, 
Salt Lake City, UT),  2mM of each deoxynucleoside triphosphate (Idaho Technology, Salt 
Lake City, UT), 0.015% SYBR Green I (Molecular Probes, Eugene, OR), .5 µM of each 
primer, 0.5 U of Taq polymerase (Invitrogen, Carlsbad, CA), 110 ng of TaqStart Ab 
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(Clontech, Palo Alto, CA), and up to 200ng of template DNA.  The primers used to detect 
B. burgdorferi recA gene were Bb-RecA-F (5’-
GTGGATCTATTGTATTAGATGAGGCTCTCG-3’) and Bb-RecA-R (5’-
GCCAAAGTTCTGCAACATTAACACCTAAAG-3’).  Each of 45 amplification cycles 
comprised of heating at 20°C/s to 94°C with a 1-s hold, primer annealing at and 66°C for 
15 s, primer extension at 70°C for 20 s, and heating at 1°C/s to 84°C to acquire the 
specific fluorescence of the PCR product in each cycle.  B. burgdorferi copy numbers 
were calculated by comparing the threshold cycle values with the values for serial 
dilutions of known amounts of B. burgdorferi N40 genomic DNA in 50ng/µl of mouse 
DNA which were used as standards. 
 
Enzyme-Linked Immunosorbent Assay 
B. burgdorferi-specific antibodies were measured by enzyme-linked immunosorbent 
assay (ELISA).  NUNC Maxisorp 96-well plates (Thermo Fisher Scientific, Wilmington, 
DE) were coated with B. burgdorferi N40, recombinant DbpA (rDbpA), or the 
diacylglycerol glycolipid, BbGL-IIc.   ELISA’s for N40 and rDbpA were carried out with 
similar reagents, but the BbGL-IIc ELISA was adapted from a previous paper [50] and 
required slightly different reagents.  In vitro grown N40 was thawed, washed, heat-killed 
at 42° for 1 hour, and 106 spirochetes were added to each well in phosphate buffered 
saline (PBS).  rDbpA was made as previously described [63].  100ng of rDbpA in 50mM 
Sodium Carbonate, 50mM Sodium bicarbonate buffer, at pH 9.6, was added to each well.  
BbGL-IIc (generously provided by Mitchell Kronenberg) was made as previously 
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described [47], and 100ng of BbGL-IIc was added to each well in blocking buffer (PBS, 
0.5% bovine serum albumin [BSA], 0.1% Tween 20).  Plates were stored overnight at 4° 
and made fresh the day before.  
Antigens were discarded and blocking buffer (50mM Tris, 140mM NaCl, 1% BSA) was 
added to plates coated with N40 and rDbpA for 1 hour at room temperature.  To perform 
ELISA, plates were washed with wash buffer (50mM Tris, 140mM NaCl, 0.1% BSA, 
0.025% Tween-20) and serial dilutions of serum in dilution buffer (50mM Tris, 140mM 
NaCl, 1% BSA, 0.025% Tween-20) were added to each well at 50µl per well and 
incubated at room temperature for 3 hours.  The plates were washed, then goat-anti-
mouse AP-conjugated antibodies (Bethyl Laboratories, Montgomery, TX) were added 
and incubated for 1 hour at room temperature with anti-IgM (1:1,000), anti-IgG (1:10,000 
or 1:5,000 for BbGL-IIc coated plates), anti-IgG1 (1:500), anti-IgG2b (1:10,000), anti-
IgG2c (1:10,000; used instead of anti-IgG2a because C57BL/6 mice generate IgG2c rather 
than IgG2a), or anti-IgG3 (1:500).  After washing, 200µl of 4-nitrophenol phosphate in 
glycine buffer (0.1M glycine, 1mM MgCL2, 1mM ZnCl2, pH 10.4) was added to each 
well.  The plates were read at 30° in a SpectraMax 250 (Molecular Devices, Sunnyvale, 
CA) 96-well plate reader at OD405 for 30 minutes with readings taken every 30 seconds. 
Vmax (milli-optical density units per minute [mOD/min]) was calculated for each sample 
with Softmax Pro Software v5.5 (Molecular Devices, Sunnyvale, CA).  To standardize 
each experiment, dilutions of serum from pooled B. burgdorferi-infected donor mice, 
stored as frozen aliquots, were run in parallel with every set of sample sera. The product 
of Vmax x inverse serum dilution factor was calculated, and in pilot experiments, 
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determined three or four successive dilutions for which this product was largely 
independent of serum dilution factor.  The arbitrary units of a given serum sample was 
chosen as the largest Vmax x inverse serum dilution factor product within that dilution 
range, and was expressed relative to the arbitrary units of control pooled sera, which was 
set to 100 units. Note that the same control serum was used for every ELISA, allowing 
for direct comparison of antibody units between experiments.   
 
Western Blots 
Frozen bacterial pellets were thawed and lysed in 2x Laemmli buffer at 100° for 5 
minutes, and the equivaent of 5x107 spirochetes were loaded into each well of an 18% 
SDS-PAGE gel.  The proteins separated by electrophoresis were transferred to 
Immobilon-P polyvinylidene difluoride (PVDF) membranes (Millipore, Billerica, MA).  
Membranes were blocked for 30 minutes at 4° with 5% milk in phosphate-buffered saline 
(PBS) and incubated with 4 week-infected immune serum diluted in blocking buffer at 
various dilutions at 4° overnight.  After washing, immunoblots were probed at 1:10,000 
with affinity-purified goat-anti mouse IgG (heavy and light chains) conjugated to alkaline 
phosphatase (Promega, Madison, WI) at 4° for 1 hour.  Bands were detected in a high pH 
Buffer (100mM NaCl, 100mM Tris, pH=9.5, 5mM MgCl2) containing a substrate 
solution of 5-bromo-4-chloro-3-indolyl phosphate in dimethyl formamide and nitroblue 
tetrazolium (Sigma-Aldrich, St. Louis, MO). 
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Histopathology 
Tissue preparation and arthritis and carditis scoring were performed as previously 
described [33, 37, 39, 64].  Briefly, left hind limbs and the left side of the heart (bisected 
in a sagittal plane) were stored in neutral-buffered formalin (pH=7.2).  Bones were 
demineralized and tissue sections were stained with hematoxylin-eosin by standard 
practices, to assess inflammation.  Arthritis severity was determined for one knee and 
tibiotarsal joint from each mouse and was scored on a scale of 0 (negative) to 3 (severe).  
Arthritis scores for each mouse are represented as the mean for the group ± the standard 
deviation (SD).  Active inflammation was assessed in the heart sections and was 
determined to be inactive, active or chronic and inactive.   
 
Statistics and Data Analysis 
The students unpaired, two-tailed t test was used to calculate statistical differences 
between two mouse groups.  To compare multiple groups, we used the one-way analysis 
of variance (ANOVA) flowed by Tukey’s multiple comparison test (GraphPad Prism, 
Version 5.03 for Windows, La Jolla, CA).  Differences were considered significant when 
p values lower than 0.05 were calculated. 
 
To determine the correlation between antibody titer and bacterial load during B. 
burgdorferi infections, the data for antibody units and copy number were transformed to 
log base 10 and then plotted on an X, Y scatter plot so that antibody isotype was plotted 
against B. burgdorferi copy number (GraphPad Prism).  The plotted values were fitted 
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with a linear regression line.  A negative slope indicated a negative correlation between 
antibody titer and bacterial load: as antibody titer increased, bacterial load decreased.  A 
slope near zero indicated no correlation.  The slope of each line was graphed and p > 0.05 
(*) indicates slope values significantly non-zero.   
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Results 
T cell-deficient mice generate low levels of anti-B. burgdorferi antibody and suffer 
high levels of colonization 
While T cells are not required for generating a protective antibody response during B. 
burgdorferi infection, their exact role in providing protection against colonization has not 
been previously determined.  A careful assessment of the level of tissue colonization 
between wild type mice and mice devoid of T cells has not previously been established.     
 
To elucidate the contribution of T cells in clearing B. burgdorferi from tissues, we 
compared B. burgdorferi infection in wild type mice and T cell-deficient (TCRβxδ-/-) 
mice.  Four weeks after challenge, we quantified the antibody response to B. burgdorferi 
and found that IgM levels were similar for wild type and TCRβxδ-/- mice (WT: ~55 units, 
TCRβxδ-/-: ~45 units, Figure 6A, “N40”), which was expected since IgM is typically 
generated during a T-independent immune response.  The IgG response was muted 
compared to wild type mice and TCRβxδ-/- mice produced 20-fold less B. burgdorferi-
specific IgG (WT: 40 units, TCRβxδ-/-: 2 units).   
 
We also quantified the IgG subclasses in order to learn which isotypes could be generated 
independent of T cells.  Previous work documented multiple antibody isotypes generated 
by B. burgdorferi-infected T cell-deficient mice but antibody titers were about 3 to 10 
times lower than wild type mice [33].  As expected, TCRβxδ-/- mice generated multiple 
isotypes of anti-B. burgdorferi antibody, but the titers were significantly reduced  
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Figure 6.  T cell-deficient mice generate low levels of anti-B. burgdorferi antibody and suffer high 
levels of colonization, and protection from joint colonization occurs when CD40L is inhibited.  
Immunocompromised RAG1-/- mice (●), WT mice treated with anti-CD40L antibody MR1 (▼, WT-MR1), 
WT (■) or TCRβxδ-/- (▲) were infected with B. burgdorferi. At 4 weeks post infection, sera and tissues 
were collected.  Data points represent individual mice, red lines indicate group means and bars are the 
SEM. A. Serum was titered for anti-B. burgdorferi (upper panels), anti-DbpA (middle panels) and BbGL-
IIc (lower panels) antibodies by ELISA.  As a control, dilutions of serum from B. burgdorferi-infected 
donor mice were run in parallel, and dilutions of sample serum were normalized to the control serum which 
was defined as 100 antibody units.  Pooled serum from uninfected mice (Non-Immune) was also included 
as a control and was not displayed on graphs if the values were zero. Significant (p<0.05) differences 
compared to WT mice were determined by the one-way ANOVA followed by Tukey’s post hoc multiple 
-/-
RA
G1 W
T -/-δxβ
TC
R
W
T-
M
R1
1
10
100
1000
10000 *
B
ac
te
ri
al
 L
oa
d
(B
b 
C
op
ie
s/
10
0n
g 
M
ou
se
 D
N
A
)
-/-
RA
G1 W
T -/-δxβ
TC
R
W
T-
M
R1
0.1
1
10
100
1000
10000
Knee Heart
0
20
40
60 p<0.0001
0
20
40
60
80
0
20
40
60
0
20
40
60 p 0.0001
0
20
40
60
80
0
20
40
60
80
100
0.00.5
10
20
30
40 p<0.0001
0
10
20
30
W
T -/-δxβ
TC
R
W
T-
MR
1
0
10
20
30
40
W
T -/-δxβ
TC
R
W
T-
MR
1
0
10
20
30
40
W
T -/-δxβ
TC
R
W
T-
MR
1
0
10
20
30
40
50
W
T -/-δxβ
TC
R
W
T-
MR
1
0
50
100
150
200
W
T -/-δxβ
TC
R
W
T-
MR
1
No
n-I
mm
un
e
0
50
100
150
200
W
T -/-δxβ
TC
R
W
T-
MR
1
No
n-I
mm
un
e
0
50
100
150
IgM IgG3IgG2cIgG2bIgG1IgG
N40
DbpA
BbGL-IIcA
nt
ib
od
y 
U
ni
ts
C.
A.
B.
Un-reconstituted Infections
Db
pA
B
Db
pB
-- Db
pA
rD
bp
A
W
T
N40B314
Db
pA
B
Db
pB
-- Db
pA
rD
bp
A
W
T
N40B314
Db
pA
B
Db
pB
-- Db
pA
rD
bp
A
W
T
N40B314
TCR
40
25
20
15
10
Δd
bp
BA
WT βxδ-/- WT-MR1
1 2 3 4 5 6 7 1 2 3 4 5 6 7 1 2 3 4 5 6 7
Δd
bp
BA
Δd
bp
BA
51 
 
 
comparison test and are indicated by brackets.  Displayed p-values indicate that all 3 groups are 
significantly different from one another.  B. Whole lysates of B. burgdorferi strain N40, B314 (--) (which 
lacks the endogenous plasmid that encodes DbpA/B), B314 harboring plasmids expressing either DbpA 
and DbpB (DbpA, DbpB) or expressing both plasmids (DbpAB) and N40 lacking DbpA and DbpB 
(ΔdbpBA) were probed with pooled serum from WT mice (1:4,000), WT-MR1 mice (1:4,000) or TCRβxδ-/-  
mice (1:250).  Arrows indicate DbpA. C. The bacterial burden was determined by qPCR of B. burgdorferi 
DNA relative to 100ng of mouse DNA at 4 weeks post challenge.  Significant (p<0.05) differences 
compared to unreconstituted mice were determined by the one-way ANOVA followed by Tukey’s post hoc 
multiple comparison test and are indicated by brackets.  The asterisk designates this group as statistically 
different from all others. 
compared to wild type mice (Figure 6A, “N40”).  IgG2b was virtually undetectable in 
TCRβxδ-/- mice (0.5 units).  IgG1 was reduced 19-fold compared to wild type mice (WT: 
32 units, TCRβxδ-/-: 1.7 units), IgG2c decreased by ~5-fold (WT: 48 units, TCRβxδ-/-: 10 
units) and IgG3 was reduced ~5-fold (WT: 63 units, TCRβxδ-/-: 12 units).  Infection of T 
cell-deficient mice indicates that T cells are important in generating a robust B. 
burgdorferi-specific antibody response. 
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To determine the repertoire of antigens recognized by wild type and T cell-deficient 
mice, extracts of B. burgdorferi strain N40 were used for immunoblots with the same 
immune sera used for ELISA.  We found that pooled sera from TCRβxδ-/- mice 
recognized far fewer protein species than sera from wild type mice (Figure 6B, “WT” 
and “TCRβxδ-/-”).  Wild type immune sera recognized at least 6 prominent bands of 
apparent molecular weight between 15 and 40kDa while sera from TCRβxδ-/- mice 
recognized ~3 prominent bands between 10 and 20kDa.  Reflective of the weak antibody 
response by ELISA, high concentrations of pooled sera from TCRβxδ-/- mice were 
needed to visualize any protein species by immunoblotting (TCRβxδ-/-: 1:250 vs. WT: 
1:4,000).  Furthermore, the repertoire of B. burgdorferi N40 proteins was greatly reduced 
in TCRβxδ-/- compared to wild type mice (compare Figure 6B, lane 5, “N40 WT”, for 
left and central panels), suggesting that the T independent immune response is more 
restricted.   
 
A previously identified protective antigen generated in the absence of T cells is the ~19 
kD surface-exposed lipoprotein, decorin binding protein (Dbp) A [33, 37].  DbpA is 
encoded in a bicistronic operon that also includes the gene encoding DbpB, a related 
decorin-binding lipoprotein [25]. As expected, pooled sera from both wild type and 
TCRβxδ-/- mice recognize recombinant DbpA (Figure 6B, lane 7, “rDbpA”).  This 
result supports the idea that T cells are not required to generate an anti-DbpA antibody 
response, but did not definitively address whether any of the protein species recognized 
in wild type bacterial lysates corresponded to DbpA.  Wild type sera did recognize an 
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~19 kDa band (Figure, 6B, lane 5, “N40 WT”), and this same band was much less 
prominent in TCRβxδ-/- mouse sera.   
 
Evidence that the band was indeed DbpA came from immunoblotting two sets of 
recombinant B. burgdorferi strains that specifically differ in the expression of DbpA.  
First, we found that the 19 kDa species was absent upon immunoblotting wild type and 
TCRβxδ-/- sera against mutant strain lacking DbpA and DbpB, strain N40ΔdbpBA 
(Figure 6B, “N40 ΔdbpBA; lane 6).  Second, B. burgdorferi strain B314 is a high 
passage, non-infectious derivative of B. burgdorferi strain 31 that lacks all linear 
plasmids [V. Benoit, pers. comm.], including the one that encodes the dbpBA operon 
[60].  We found that the 19 kDa species was absent in both wild type and TCRβxδ-/- sera 
upon immunoblotting strain B314 harboring an empty shuttle vector (Fig. 6B,”B314”; 
lane 3). In contrast, the 19 kDa species was strongly apparent upon immunoblotting of 
isogenic B314 derivatives that carry shuttle vectors encoding either both DbpA and 
DbpB, or DbpA alone by wild type serum, and TCRβxδ-/- serum was weakly reactive to 
this band ([27] Fig. 6B, “DbpAB” or “DbpA”; lanes 1 and 4, respectively).  A fainter 
band of ~18 kDa was apparent when wild type serum was used to probe B314 expressing 
both DbpA and DbpB or DbpB alone, and TCRβxδ-/- mouse serum was somewhat more 
strongly reactive to this band (Fig. 6B, “DbpB”; lane 2), indicating that DbpB is likely 
also recognized.  These results show that B. burgdorferi-infected TCRβxδ-/- mice 
generate antibodies against DbpA, consistent with previous reports [33], and also against 
DbpB.   
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To quantitate the anti-DbpA antibody response detected by Western blot we used 
recombinant DbpA in ELISAs.  In contrast to the B. burgdorferi-specific IgM response, T 
cells were important for producing DbpA-specific IgM since TCRβxδ-/- mice produce 
2.5-fold less of this antibody than wild type mice (WT: 24 units, TCRβxδ-/-: 8 units; 
Figure 6A, “rDbpA”).  The IgG response against DbpA was more dramatically 
diminished: IgG was barely detected and was >100-fold less than wild type mouse sera 
(WT: 22 units, TCRβxδ-/-: 0.2 units).  DbpA-specific IgG1 was not generated in TCRβxδ-
/- mice and IgG2b and IgG2c were weakly produced (0.07 and 0.4 units, respectively).  
IgG3, an isotype commonly generated during a T-independent immune response, was the 
only IgG subclass that was detectable in all mice and was lower, although not 
significantly, than the anti-DbpA IgG3 titer in wild type mice (WT: 17 units, TCRβxδ-/-: 
2 units).  The ELISA confirmed quantitatively that the anti-DbpA response in B. 
burgdorferi-infected TCRβxδ-/- mice is muted compared to wild type mice and that T 
cells are required for high-level production of anti-DbpA antibodies.     
   
Although immunoblotting was crucial for defining the B. burgdorferi protein antigens 
recognized by immune sera, non-protein antigens are not readily detected by this 
technique. In particular, B. burgdorferi expresses a CD1d-restricted diacylglycerol 
glycolipid antigen, BbGL-IIc [47], and antibodies directed against this glycolipid are 
readily detected in mouse and human immune serum [48, 50].  Thus, we measured the 
glycolipid antibody response by ELISA using purified BbGL-IIc.  BbGL-IIc-specific 
IgM was similar for wild type and TCRβxδ-/- mice (~100 units), but TCRβxδ-/- mice 
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made significantly less (~3.5-fold) anti-BbGL-IIc IgG to this antigen compared to wild 
types mice (WT: 90 units, TCRβxδ-/-: 26units; Figure 6A, “BbGL-IIc”).  Taken 
together, these results suggest that T cells are necessary for generating a robust antibody 
response during infection with B. burgdorferi, and anti-DbpA and anti-BbGL-IIc 
antibodies are significantly reduced in the absence of T cells. 
 
To determine whether these antibody responses were associated with immunologic 
protection, we determined pathogen burden by quantitative PCR (qPCR).  The poor IgG 
response by T-deficient mice was associated with a high bacterial load.  Bacterial 
numbers in the knee were 10-fold higher than those found in wild type mice, and were 
only slightly (4-fold and not significantly) lower from those observed upon infection of 
RAG1-/- mice (Figure 6C, “Knee”).  Bacterial numbers in the heart were 50-fold higher 
than those found in wild type mice (Fig. 6C, “Heart”).  Unlike reconstitution of RAG1-/- 
mice with TCRβxδ-/- peritoneal cells, we did not find a statistical difference in bacterial 
load in the heart between RAG1-/- and TCRβxδ-/- mice.  However, there was a moderate 
reduction (5-fold) of spirochetes in TCRβxδ-/- mice compared to RAG1-/- mice suggesting 
that a T-independent response may contribute to clearance of B. burgdorferi from the 
heart as well as the knee.  Nevertheless, these data indicate T cells are required for 
abundant antibody production and efficient clearance of spirochetes from the joint and 
heart.   
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Protection from B. burgdorferi joint colonization occurs in the absence of CD40-
CD40L interactions  
After a T cell encounters antigen presented by a B cell, CD40 ligand (CD40L) on the 
activated T cell engages CD40 expressed on the surface of the B cell, triggering B cell 
division and antibody isotype switching.  Previous reports have demonstrated that 
protective antibody against B. burgdorferi are still generated in mice lacking CD40L, but 
the degree of tissue colonization was not determined [43].  To estimate the degree to 
which the T cell help to B cells during Lyme infection is dependend on CD40L, we 
infected mice after treatment with antibody (MR-1) that blocks CD40L. 
 
As predicted, treatment with MR-1 resulted in a greater than ten-fold decrease in IgG 
antibodies that recognize the T-dependent antigen NP-CGG, indicating that CD40L-
dependent T cell help was effectively blocked in these mice (Figure 7, “WT and WT-
MR1”).  In B. burgdorferi-infected mice, blocking CD40L did not inhibit the production 
of B. burgdorferi-specific IgM, consistent with this response being T-independent 
(Figure 6A, “N40”).  However, IgG was reduced approximately 3-fold compared to WT 
mice (WT: 40 units, WT-MR1: 15 units) indicating CD40L conferred some function in 
the context of IgG production. 
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Figure 7.  CD40L is inhibited with anti-CD40L antibody treatment.  Three B6 mice were treated with 
0.5mg of anti-CD40L antibody (MR-1) every 4 days starting 7 days prior to antigen injection and continued 
throughout the study.  On day zero the MR-1-treated mice (WT-MR1) and 3 untreated mice (WT) were 
immunized with 50µg of NP-CGG.  Blood was collected 21 days after immunization.  Serum was titered 
for anti-NP-CGG antibodies by ELISA.  The mean activity of WT mice was set to 100 antibody units, and 
the activity of WT-MR1 mice was normalized to this value.  Pooled serum from uninfected mice (Non-
Immune) was also included as a control. 
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We chose to look at IgG subclasses because certain isotypes are preferentially induced by 
particular cytokines–e.g. IL-4 induces IgG1, IFN-γ induces IgG2a, IgG3 and TGF-β 
induces IgG2b–providing a way to indirectly assess the cytokine milieu.  CD40L-blocked 
mice produced similar levels of IgG1 compared to wild type mice (~30 units each) and 
had significantly less IgG2b (WT: 43 units, WT-MR1: 9 units) and IgG3 (WT: 63 units, 
WT-MR1: 22 units), indicating the requirement of CD40L in producing some of the 
portion of these isotypes during infection with B. burgdorferi.  Conversely, anti-CD40L-
treated mice generated significantly more IgG and every IgG subclass compared to 
TCRβxδ-/- mice, with the most dramatic difference between IgG1 (TCRβxδ-/-: 1.7 units, 
WT-MR1: 32 units) and IgG2b (TCRβxδ-/-: 0.5 units, WT-MR1: 17 units), indicating a 
function for T cells beyond provision of CD40L in generating antibodies directed towards 
B. burgdorferi.  
 
B. burgdorferi-infected TCRβxδ-/- mice did not generate antibodies against as large a 
repertoire of antigens compared to wild type mice.  Therefore, we wanted to determine 
the repertoire of antigens detected in sera from mice with T cells incapable of providing 
efficient T cell help.  Immunoblotting revealed that CD40L is required for recognition of 
multiple protein species in that sera from anti-CD40L treated mice recognized a very 
limited set of protein antigens from B. burgdorferi lysates (~17, 18, 19kDa) compared to 
untreated mice at a 1:4,000 dilution (Figure 6B, “WT-MR1” N40, lane 5).    
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Since TCRβxδ-/- mice generate antibodies against DbpA, it was not surprising that sera 
from CD40L-blocked mice also generated antibodies that recognized recombinant DbpA 
(Figure 6B, lane 7, “rDbpA”).  To confirm that the prominent 19kDa band detected in 
wild type N40 lysates was DbpA we found that the band was absent in the mutant strain 
lacking DbpA and DbpB (Figure 6B, “N40ΔdbpBA”, lane 6) and in B314 carrying an 
empty shuttle vector (Figure 6B, “B314, --”, lane 3).  Sera from CD40L-blocked mice 
also reacted to bands in B314 expressing both DbpA and DbpB or DbpA alone (Figure 6, 
“B314, DbpAB or DbpA”, lanes 1 and 4, respectively).  Furthermore, sera also reacted 
weakly to the ~18kDa band found in B314 expressing DbpB (Figure 6, “B314, DbpB”, 
lane 2).  The immunoblots revealed that DbpA and, to a lesser extent DbpB, are the 
predominant protein antigens recognized by mice in which CD40L is impaired (Figure 
6B, right panel).  
 
Consistent with this observation, ELISAs with DbpA revealed that MR1-treated mice 
generated roughly equivalent levels of anti-DbpA IgM antibody compared to untreated 
WT mice (~ 20 units each; Figure 6A, “rDbpA”) and significantly more than TCRβxδ-/- 
mice (8 units).  IgG3 was also not significantly affected by blocking CD40L and levels 
were comparable to that of TCRβxδ-/- mice (WT: 17, TCRβxδ-/-: 2.1 units, WT-MR1: 6). 
However, total IgG was significantly reduced compared to WT mice (WT: 23 units, WT-
MR1: 17 units) as was IgG2c (WT: 21 units, WT-MR1: 4 units), indicating the 
requirement for CD40L in producing some of the portion of these isotypes during 
infection with B. burgdorferi.  Conversely, anti-CD40L-treated mice generated 
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significantly more IgG1 compared to WT mice (WT: 20 units, WT-MR1: 92) suggesting 
that blocking CD40L may enhance the generation of IgG1 against rDbpA. These results 
are consistent with the idea that DbpA-specific antibodies are produced in the absence of 
CD40L-CD40 interactions.   
 
The protein antigenic repertoire represented by immunoblot was enriched for DbpA. 
Thus, we wanted to determine if inhibiting CD40L would diminish the antibody response 
to the glycolipid antigen BbGL-IIc.  In fact, neither IgM nor IgG are significantly 
reduced compared to wild type mice (Figure 6A, “BbGL-IIc”; IgM, WT: 105 units, 
WT-R1: 102 units and IgG, WT: 90 units, WR-MR1: 71 units).  This result demonstrates 
that T cell help via CD40L is not required for generating an antibody response against 
BbGL-IIc. 
 
CD40L-blocked mice are significantly protected from joint colonization compared to 
RAG1-/- and TCRβxδ-/- mice (18- and 2-fold, respectively) and only 1.8-fold higher than 
wild type mice (Figure 6C, “Knee”).  Similarly, CD40L-blocked mice have significantly 
less heart colonization compared to TCRβxδ-/- mice (7-fold), 34-fold less than RAG1-/- 
mice and ~7-fold more than wild type mice (Figure 6C, “Heart”).  These data support 
the idea that CD40L plays a relatively minor role in generating an antibody response to 
DbpA and in clearing spirochetes from tissues during Lyme infection. 
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B. burgdorferi- and BbGL-IIc specific IgM do not correlate with protection against 
bacterial colonization    
We wanted to determine if there was a correlation between antibody titer and B. 
burgdorferi colonization.  The data represented in Figure 6 suggests that in general, mice 
with higher antibody titers also exhibit lower bacterial loads (wild type mice) and mice 
with low antibody titers maintain high bacterial loads (TCRβxδ-/-).   
 
To more directly identify a relationship we generated a series of correlation graphs and fit 
them with linear regression lines and graphed the slope of each line (Figure 8A).  A p > 
0.05 signifies a significant correlation between antibody titer and bacterial load: As 
antibody titer increases, bacterial load decreases.  This relationship generates a negative 
correlation (negative slope).  Slope values further away from zero represent greater 
correlations.  To generate a sloped line, values representing a broad range of data are 
required: high antibody titer vs. low copy number and low antibody titer vs. high copy 
number.           
 
N40-specific IgG, IgG1, IgG2b, IgG2c and IgG3 are all significantly correlated with 
bacterial load in the knee and heart, suggesting that these isotypes are important for  
generating protection against colonization (Figure 8B, “N40”).  Not surprisingly, N40-
specific-IgM is not significantly correlated with colonization in either the knee or the 
heart.  There were no differences in IgM titers between wild type, TCRβxδ-/- or CD40L- 
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Figure 8.  B. burgdorferi- and BbGL-IIc- specific IgM does not correlate with protection against 
bacterial colonization.  A. Schematic for determining the correlation between antibody titer and bacterial 
colonization.  (1) To determine if antibody titer and bacterial loads are correlated, the data for antibody 
units and B. burgdorferi copy number were transformed to log base 10 and then plotted on an X, Y scatter 
plot so that antibody isotype was plotted against B. burgdorferi copy number.  The data from all mice in the 
experiment were plotted together (N=15).  The data represented here are N40-specific IgM and IgG plotted 
against B. burgdorferi copy numbers in the knee.  (2) The plotted values were fitted with a linear regression 
line.  A negative slope indicates a negative correlation between antibody titer and bacterial load: as 
antibody titer increases, bacterial load decreases (IgG).  A slope near zero indicates no correlation (IgM).  
(3) The slope of each line was graphed and p > 0.05 (*) indicates slope values significantly non-zero.  The 
bars indicated the 95% confidence interval.  B.  Correlation values for each isotype of N40-, DbpA- and 
BbGL-IIc specific antibodies and colonization of the knee and heart in B. burgdorferi-infected wild type, 
TCRβxδ-/- and CD40L-blocked wild type mice.  p > 0.05 indicates a significantly non-zero slope; the data 
are correlated. 
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blocked mice, yet TCRβxδ-/- mice suffered from significantly higher bacterial loads 
(Figure 6A and C) suggesting IgM is not sufficient for controlling colonization.   
 
DbpA-specific IgG, IgM, IgG2b, IgG2c and IgG3 are correlated with colonization in the 
knee and in the heart (Figure 8B, “DbpA”).  IgG1 is not correlated and may be 
explained by the lack of data points because too few mice generated DbpA-specific 
antibody of this isotype.  That DbpA-specific IgM is significantly correlated with  
   
 
bacterial load is reflected in the DbpA-specific antibody response: TCRβxδ-/- mice 
generated a 2.5-fold lower titer compared to wild type mice and CD40L-blocked mice 
(Figure 6A, “DbpA”). 
 
BbGL-IIc-specific IgG was significantly correlated with bacterial load in the knee and 
heart (Figure 8B, “BbGL-IIc”).  Similar to the IgM response seen against N40, IgM-
specific BbGL-IIc was not significantly different between wild type and TCRβxδ-/- mice 
and the IgG response was significantly lower in T cell-deficient mice.   
 
Taken together, these data indicate that antibody titer is directly correlated with bacterial 
load: as antibody titer increases, bacterial load decreases.  IgG titers (and the IgG 
subclasses) appear to more strongly determine the outcome of bacterial load as mice with 
high IgG titers have reduced bacterial loads.  This suggests that T cells are critical for 
protection against colonization since TCRβxδ-/- mice have reduced antibody titers which 
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likely results in increased colonization.  Aside from DbpA-specific IgM, IgM is not 
correlated with bacterial load.  Similar correlation analyses were performed for the 
following experiments, but no particular isotype was correlated with clearance.  
Therefore the data is excluded from the following experiments. 
 
Mice deficient in secreted IgM do not suffer from increased tissue colonization by B. 
burgdorferi  
B. burgdorferi-infected TCRβxδ-/- mice generate barely detectable IgG titers.  However, 
they produce an N40- and BbGL-IIc-specific IgM titer equivalent to that of wild type 
mice, and the DbpA-specific IgM response is 2-fold lower in T cell-deficient mice.  
Despite the high IgM titer TCRβxδ-/- mice suffer from a significantly higher bacterial 
load in both the knee and the heart suggesting that IgM is not sufficient for providing 
protection against colonization.  Additionally, N40- and BbGL-IIc-specific IgM is not 
significantly correlated to bacterial colonization in the knee or heart. 
 
To determine if IgM is important for controlling high level B. burgdorferi colonization, 
we infected mice deficient in secreted IgM (sIgM-/-) but maintain the membrane bound 
form [65].  sIgM-/- mice are on a 129Sv background and were used as controls.  We also 
infected C57Bl/6 (B6) mice to compare bacterial loads since 129 mice are not commonly 
used for B. burgdorferi infections.  Four weeks after infection, knees and hearts were 
harvested for qPCR.   Bacterial numbers in the knee and heart were not significantly 
different between B6, 129 or sIgM-/- mice (Figure 9), indicating that the absence of IgM  
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Figure 9.  Mice deficient in secreted IgM do not suffer from increased levels of colonization by B. 
burgdorferi.  C57Bl/6 (■, WT(B6)), sIgM-/- (▲), and 129/SvJ (▼, WT(129)) mice were infected with B. 
burgdorferi. At 4 weeks post infection tissues were collected.  Data points represent individual mice, red 
lines indicate group means and bars are the SEM.  The bacterial burden was determined by qPCR of B. 
burgdorferi DNA relative to 100ng of mouse DNA at 4 weeks post challenge.   
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does not lead to greater bacterial loads and further supporting the idea that IgM is not 
required for protection against colonization.   
 
Peritoneal cells from naïve or previously infected C57Bl/6 mice confer significant 
protection from infection by B. burgdorferi 
Wild type mice demonstrated 10-100-fold better protection against tissue colonization 
against B. burgdorferi than immunodeficient RAG1-/- mice indicating that T and/or B  
 
cells are important in generating protection.  We wanted to determine what cells were 
responsible for conferring protection against B. burgdorferi and chose to look at 
peritoneal cells because transfer of peritoneal cells enriched for B1b cells protected 
RAG1-/- mice from subsequent B. hermsii  infection [56].  
After four weeks of infection with B. burgdorferi, peritoneal cells were harvested from 
C57Bl/6 mice and transferred into RAG1-/- mice at 2:1 donor to recipient ratio.  Transfer 
of naïve donor cells to RAG1-/- mice was performed in parallel.  Two weeks after 
transfer, recipient mice were infected i.d. with 2x104 spirochetes.  Four weeks after 
inoculation, peritoneal cells transferred from naïve or previously infected (convalescent) 
WT mice produced a B. burgdorferi-specific IgM and IgG response in reconstituted 
RAG1-/- mice (Figure 10A, “N40”).  Overall, the IgM and IgG responses were 
comparable for recipients of either naïve cells or cells from convalescent mice. 
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Figure 10.  Peritoneal cells from naïve or previously infected B6 mice confer significant protection 
from infection by B. burgdorferi. Immunodeficient RAG1-/- mice were either unreconstituted (●, No 
Cells), or reconstituted with peritoneal cells from uninfected (■, Naïve) or infected (▲, Conv) donors. 
Recipient RAG1-/- mice were challenged with 2x104 B. burgdorferi by i.d. injection, and at 4 weeks post 
challenge, sera and tissues were collected.  Data points represent individual mice, red lines indicate group 
means, and bars are the standard error of the mean (SEM). A. Serum was titered for anti-B. burgdorferi 
(upper panels) and anti-DbpA (lower panels) antibodies by ELISA.  As a control, dilutions of serum from 
B. burgdorferi-infected donor mice were run in parallel, and dilutions of sample serum were normalized to 
the control serum which was defined as 100 antibody units.  B. The bacterial burden was determined by 
qPCR of B. burgdorferi DNA relative to 100ng of mouse DNA at 4 weeks post challenge.  Dotted lines 
indicate detection limits of less than 0.001 copies of B. burgdorferi DNA.  Significant (p<0.05) differences 
compared to unreconstituted mice were determined by the one-way ANOVA followed by Tukey’s post hoc 
multiple comparison test and are indicated by brackets. 
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Similarly, RAG1-/- mice reconstituted with naïve or convalescent peritoneal cells 
generated an IgM and IgG response to DbpA (Figure 10A, “DbpA”).  This response was 
indistinguishable between mice reconstituted with naïve or convalescent peritoneal cells. 
 
To determine whether these antibody responses were associated with immunologic 
protection, we determined pathogen burden by qPCR. Peritoneal cells from naïve donors 
significantly reduced colonization of the knee and heart 9- and 8-fold, respectively 
(Figure 10B, “Knee” and “Heart”).  Cells from convalescent donors significantly 
diminished spirochete burden of the respective tissues ~300- and 500-fold. Thus, 
peritoneal cells from either naïve or convalescent mice produce pathogen-specific 
antibody and protect upon challenge of immunodeficient mice with the Lyme spirochete, 
with a greater degree of protection conferred by transfer of cells from convalescent mice.  
 
T cells contribute to protection against B. burgdorferi joint colonization in 
reconstituted RAG1-/- mice  
T cells were required to enhance protection against colonization and antibody production 
(Figure 6), and we wanted to determine if T cells were also necessary to elicit protection 
by peritoneal cells during reconstitution of immunocompromised mice.  To determine if 
T cells contribute to protection during adoptive transfer, we reconstituted RAG1-/- mice 
with un-fractionated peritoneal cells from previously infected C57Bl/6 (WT) or TCRβxδ-
/- mice (Table 3) and infected them with B. burgdorferi .  Four weeks after challenge, we 
quantified the antibody response to B. burgdorferi.  Consistent with a role for T cells in 
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promoting an antibody response in reconstituted mice, the IgM and IgG titers against B. 
burgdorferi were greatly diminished when TCRβxδ-/- donor mice were used (IgM, WT: 
600 units, TCRβxδ-/-: 50 units; IgG, WT: 175 units, TCRβxδ-/-: 1 unit; Figure 11A, 
“N40”).       
Because TCRβxδ-/- mice generate antibody against DbpA [33], we tested whether sera 
from mice reconstituted with peritoneal cells from TCRβxδ-/- mice would similarly 
contain antibody against DbpA.  Immunoblots of pooled sera from RAG1-/- mice 
reconstituted with peritoneal cells from TCRβxδ-/- mice revealed a very limited antigenic 
repertoire against extracts of B. burgdorferi N40.  The presence of an unidentified, 
immunoreactive species that co-migrated with DbpA complicated the analysis of the anti-
DbpA response in this serum (Figure 11B, lanes 1-6).  Immunoblotting against rDbpA 
revealed that the sera was only very weakly reactive to this protein (Figure 11B, 
“rDbpA”, lane 7). 
Consistent with this, ELISA revealed that the anti-DbpA response in sera from mice 
reconstituted with TCRβxδ-/- serum was barely detectable for all IgG isotypes (<1 unit) 
(Figure 11A, “rDbpA”).  The IgM response was the only isotype that was detectable for 
all mice (<5 units) and was 10-fold lower than sera from mice reconstituted with WT 
peritoneal cells.  Thus, although T cells are not absolutely required for generating anti-
DbpA antibodies, when peritoneal cavity cells that lack T cells are adoptively transferred 
into RAG1-/- mice, they generate only a very weak anti-DbpA response.   
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Figure 11. T cells contribute to protection against B. burgdorferi joint colonization in reconstituted 
RAG1-/- mice.  Immunodeficient RAG1-/- mice were either unreconstituted (●, No Cells), or reconstituted 
with un-fractionated peritoneal cells from infected TCRβ/δ-/- mice (■, TCRβxδ-/-) or infected WT (▲, 
PerC) donors.  Recipient RAG1-/- mice were challenged with 2x104 B. burgdorferi by i.d. injection, and at 
4 weeks post challenge, sera and tissues were collected. Red lines indicate group means and bars are the 
SEM. A. Serum was titered for anti-B. burgdorferi (upper panels), anti-DbpA (middle panels) and BbGL-
IIc (lower panels) antibodies by ELISA.  As a control, dilutions of serum from B. burgdorferi-infected 
donor mice were run in parallel, and dilutions of sample serum were normalized to the control serum which 
was defined as 100 antibody units.    Significant differences, determined by student’s unpaired T-test are 
indicated by brackets. B.  Whole lysates of B. burgdorferi strain N40, B314 (--) (which lacks the 
endogenous plasmid that encodes DbpA/B), B314 harboring plasmids expressing either DbpA and DbpB 
(DbpA, DbpB) or expressing both plasmids (DbpAB) and N40 lacking DbpA and DbpB (ΔdbpBA) were 
probed with pooled serum from reconstituted mice at 1:100 dilution.  Arrows indicate DbpA.  C. The 
bacterial burden was determined by qPCR of B. burgdorferi DNA relative to 100ng of mouse DNA at 4 
weeks post challenge.  Significant (p<0.05) differences compared to unreconstituted mice were determined 
by the one-way ANOVA followed by Tukey’s post hoc multiple comparison test and are indicated by 
brackets.  The asterisk designates this group as statistically different from all others. 
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To determine if T cells contributed to anti-BbGL-IIc upon reconstitution of RAG1-/- 
mice, we measured this antibody by ELISA. Sera from all of the TCRβxδ-/--reconstituted 
mice generated IgM and IgG specific to BbGL-IIc (Figure 11A, “BbGL-IIc”), but this 
response was ~2-3-fold lower for IgM and IgG (IgM, WT: 200 units, TCRβxδ-/-: 100 
units; IgG, WT: ~140 units, TCRβxδ-/-: 50 units) than wild type mice.  This result 
suggests that similar to the response seen for DbpA, T cells are not necessary for 
generating an antibody response to BbGL-IIc, but they enable a more robust humoral 
response to this glycolipid.   
 
The diminished antibody response to B. burgdorferi, DbpA and BbGL-IIc correlated with 
severely diminished (or indiscernible) protection against colonization.  Peritoneal cells 
from TCRβxδ-/- mice confer a modest (although significant) degree of protection against 
B. burgdorferi colonization of the heart (~3-fold decrease compared to unreconstituted 
mice (Figure 11C, “Heart”), but no protection in the knee (Figure 11C, “Knee”).  This 
result suggests that a mild level of protection from heart colonization may be conferred 
by a T-independent response, but a T dependent response is required for resisting joint 
colonization.  
 
Peritoneal B2 cells require T cells to confer protection to reconstituted RAG1-/- mice  
N40 and DbpA IgG responses in anti-CD40L treated mice were significantly lower than 
those in WT mice, and even though tissue colonization was not significantly altered by 
blocking T cell help with anti-CD40L antibody, bacterial loads in CD40L-blocked mice 
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were ~2-fold higher compared to WT mice. These results indicate that T cell help may 
aid in generating protection, perhaps by activating B2 cells during the course of B. 
burgdorferi infection.   
 
To test this, four weeks after infection with B. burgdorferi we collected peritoneal cells 
from donor mice and transferred un-fractionated peritoneal cells, MACS-enriched B2 
cells or the combination of MACS-enriched B2  and T cells (Table 4) into RAG1-/- mice.  
Four weeks after challenging recipient mice with B. burgdorferi, we collected serum and 
measured antibody responses by ELISA.  RAG1-/- mice reconstituted with B2 cells 
produced significantly less B. burgdorferi-specific IgM compared to mice reconstituted 
with B2 and T cells while mice reconstituted with un-fractionated peritoneal cells (WT) 
had intermediate levels (WT: 199 units, B2: 24 units, B2+T: 290 units; Figure 12A, 
“N40”).  B2 cells produced barely detectable levels of IgG, and IgG was similar for un-
fractionated peritoneal cells and B2+T cells (WT: 131 units, B2: 0.45 units, B2+T: 79 
units).   
 
We examined the distribution of IgG subclasses to determine if the absence of B1 cells 
altered the antibody response.  B2 cells did not generate B. burgdorferi-specific IgG1, 
IgG2c or IgG3 and WT and B2+T cells had similar amounts of these isotypes (data not 
shown).  B2 cells did not generate B. burgdorferi-specific IgG2b and B2 and T cells was 
~1.8-fold lower than un-fractionated peritoneal cells and the difference was not 
statistically different (WT: 134 units, B2+T: 75 units).  These results demonstrated that  
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Figure 12.  Peritoneal B2 cells require T cells to confer protection to RAG1-/- mice.  Immunodeficient 
RAG1-/- mice were either unreconstituted (●, No Cells), or reconstituted with MACS-enriched B2 cells 
from infected donors (▲, B2), B2+T cells from infected donors (Δ, B2+T), or un-fractionated peritoneal 
cells from infected donors (○,WT). Recipient RAG1-/- mice were challenged with 2x104 B. burgdorferi by 
i.d. injection, and at 4 weeks post challenge, sera and tissues were collected.  Data points represent 
individual mice, red lines indicate group means and bars are the SEM.  A. Serum was titered for anti-B. 
burgdorferi (upper panels), anti-DbpA (middle panels) and BbGL-IIc (lower panels) antibodies by ELISA.  
As a control, dilutions of serum from B. burgdorferi-infected donor mice were run in parallel, and dilutions 
of sample serum were normalized to the control serum which was defined as 100 antibody units.  
Significant (p<0.05) differences compared to WT mice were determined by the one-way ANOVA followed 
No
 Ce
lls W
T B2
B2
+T
0.1
1
10
100
1000
10000
Ba
ct
er
ia
l L
oa
d
 (B
b 
C
op
ie
s/
10
0n
g 
M
ou
se
 D
N
A)
No
 C
ell
s
W
T B2
B2
+T
0.1
1
10
100
1000
10000 *
Knee Heart
A.
B.
C.
MACS-enriched B2 or B2+T
0
50
100
150
200
0
200
400
600
0
50
100
150
200
250
0
50
100
150
0
50
100
150
200
250
A
nt
ib
od
y 
U
ni
ts
W
T B2
B2
+T
0
50
100
150
W
T B2
B2
+T
0
20
40
60
200
400
600 p=0 0489
W
T B2
B2
+T
0
50
100
150
200
250
IgM IgG2bIgG
N40
DbpA
BbGL-IIc
Db
pA
B
Db
pB
-- Db
pA
W
T
N40B314
∆d
bp
BA
W
T
∆d
bp
BA
Db
pA
B
Db
pA
Db
pB
--
N40 B314
B2+T (1:4,000)B2 (1:500)
40
25
20
15
50
60
40
25
20
15
50
60
1 2 3 4 5 61 2 3 4 5 6
Ba
ct
er
ia
l L
oa
d
 (B
b 
C
op
ie
s/
10
0n
g 
M
ou
se
 D
N
A)
A
nt
ib
od
y 
U
ni
ts
74 
 
 
by Tukey’s post hoc multiple comparison test and are indicated by brackets.  B. Whole lysates of B. 
burgdorferi strain N40, B314 (--) (which lacks the endogenous plasmid that encodes DbpA/B), B314 
harboring plasmids expressing either DbpA and DbpB (DbpA, DbpB) or expressing both plasmids 
(DbpAB) and N40 lacking DbpA and DbpB (ΔdbpBA) were probed with pooled serum from mice which 
received B1 cells (1:500), B1+T cells (1:500 or 1:4,000), B2 cells (1:500) or B2+T cells (1:500 or 1:4,000).  
Arrows indicate DbpA.  C. The bacterial burden was determined by qPCR of B. burgdorferi DNA relative 
to mouse DNA at 4 weeks post challenge.  Significant (p<0.05) differences compared to unreconstituted 
mice were determined by the one-way ANOVA followed by Tukey’s post hoc multiple comparison test and 
are indicated by brackets.  The asterisk designates this group as statistically different from all others. 
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B2 cells, in the absence of T cells do not have the capacity to generate B. burgdorferi-
specific IgG antibodies and that B2 and T cells together generate antibody levels similar 
to mice reconstituted with un-fractionated peritoneal cells.  The marginal IgM response 
by B2 cells could be from polyclonal activation, as B. burgdorferi has known mitogenic 
properties [66].   
 
We wanted to determine if the antigenic repertoire recognized by B2 and T cells differed 
from that of B1b cells.  As expected based on the poor antibody response measured by 
ELISA, immunoblots revealed that sera from RAG1-/- mice reconstituted with B2 cells 
alone did not recognize any protein species in B. burgdorferi N40 lysates (Figure 12B, 
B2, “N40”, lanes 1 and 2) or any other protein species from B314 lysates (Figure 12B, 
B2, “B314”, lanes 3-6).  In contrast, sera from B2 and T cell reconstituted mice 
recognized multiple protein species from B. burgdorferi N40 lysates of ~17, 18, 19, 20, 
25 and 40kDa (Figure 12B, B2+T, “N40, WT” lane 5).  The antigenic repertoire 
resembled that of the wild type donor mouse serum (Figure 12B, “WT”) as there were 
multiple protein species detected with B2 and T immune sera.      
 
We wanted to determine if the 19kD band was DbpA as this was the most prominent 
band recognized by B1b-cell reconstituted mouse serum.  Sera from mice reconstituted 
with B2 and T cells did not recognize the ~19kDa band in the mutant N40 strain lacking 
DbpA and DbpB (Figure 12B, “N40ΔdbpBA”; lane 6) and B314 carrying an empty 
shuttle vector (Figure 12B, “B314 –”, lane 3).  The same sera recognized the 19kDa 
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band in B314 expressing DbpA and DbpB or DbpA alone, and TCRβxδ-/- serum was 
weakly reactive to this band (Figure 6B, “B314, DbpAB or DbpA”, lanes 1 and 4, 
respectively). Thus, B2 cells are also capable of generating antibodies recognizing 
DbpA, but only in the presence of T cells. 
 
To quantitate the anti-DbpA antibody response, we performed ELISAs with recombinant 
DbpA.  Sera from mice reconstituted with B2 cells produced significantly less DbpA-
specific IgM compared to mice reconstituted with un-fractionated peritoneal cells or B2 
and T cells (WT: 82 units, B2: 2 units, B2+T: 51 units; Figure 12A, “rDbpA”).  B2 cells 
did not generate any DbpA-specific IgG of any isotype.  Sera from mice reconstituted 
with B2 and T cells had ~2-fold less DbpA-specific IgG compared to mice reconstituted 
with un-fractionated peritoneal cells, but this difference did not reach statistical 
significance (WT: 68 units, B2+T : 29 units).  DbpA-specific IgG1 and IgG3 were similar 
for un-fractionated peritoneal cells and B2 and T cells (data not shown).  IgG2b was the 
only isotype that was statistically less in mice reconstituted with B2 and T cells compared 
to un-fractionated peritoneal cells (WT: 81, B2+T: 25): this suggests that B1 cells 
contribute to generating DbpA-specific IgG2b.     
 
Since B2 cells typically require T cell help for antibody production, we wanted to 
determine if anti-BbGL-IIc antibody would be increased in the presence of T cell help.  
Based on the results from (Figure 12A, “BbGL-IIc”) we predicted that the antibody 
response would remain the same because inhibiting T cell help via CD40L did not cause 
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a reduction of this antibody.  Sera from mice reconstituted with B2 cells had >5-fold less 
BbGL-IIc-specific IgM compared to sera from mice reconstituted with un-fractionated 
peritoneal cells or B2 and T cells while the latter 2 groups were similar (WT: 129 units, 
B2: 23 units, B2+T: 124 units; Figure 12A, “BbGL-IIc”).  And, as predicted, B2 cells 
did not generate an IgG response to the glycolipid and levels from un-fractionated 
peritoneal cells and B2 and T cells were similar (WT: 87, B2+T: 95).  This result 
reinforces the idea that B2 cells require T cell help to generate anti-BbGL-IIc antibodies.   
 
B2 cells alone offered no protection in the knee in reconstituted mice (Figure 12C, 
“Knee”) while un-fractionated peritoneal cells and B2 and T cells offered significant 
protection as B. burgdorferi copy numbers are ~100-fold lower compared to 
unreconstituted mice.  Significant protection in the heart is seen with each group of 
reconstituted mice while there is a trend for the un-fractionated group to have slightly 
better protection (~10-fold), compared to B2- or B2 and T- reconstituted mice Figure 
12C, “Heart”).  Based on this observation in the heart, there appears to be some tissue-
specific events. Clearance in the knee might require T cells and a robust antibody 
response, while clearance in the heart is not completely dependent on B cells and 
antibody production.  MACS-enriched B2 cells produce only barely detectable levels of 
B. burgdorferi-specific and DbpA-specific antibody and offer no protection to tissue 
colonization in the knee.  In contrast, B2 and T cells together restore the ability of the 
reconstituted mice to produce high titers of pathogen-specific antibodies and protect 
against colonization.  These results demonstrate that B2 cells need T cell help to 
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contribute to the response to B. burgdorferi infection and that the slight decrease (knee: 
~1.8-fold, heart: ~7-fold) in colonization when CD40L was blocked was most likely due 
to inhibition of B2:T cell interactions.  
 
Transfer of a population of peritoneal cells enriched for B1b cells from previously 
infected B6 mice confers partial protection from B. burgdorferi infection 
Blocking CD40L resulted in a partially protective immune response indicating a role for 
B cells to generate protection in the absence of CD40L:CD40 interactions.  B1 cells are 
abundant in the peritoneal cavity and can produce antibody with or without interaction of 
CD40L:CD40 and can also utilize T cell-derived factors without direct T cell-B cell 
interactions [67].  We and others have demonstrated that a subset of peritoneal B1 cells, 
B1b cells, expanded in response to B. burgdorferi infection by about 2-fold (data not 
shown) [58].  Additionally, B1b cells generated a robust antibody response to the related 
spirochete B. hermsii in the absence of T cells [55, 56].  This pathogen-specific response 
coincided with the eradication of the bacteria and also conferred long-term immunity to 
reinfection.  Since B. burgdorferi can also elicit T-independent immune responses [33], 
we investigated the role of B1b cells in providing a degree of protection against infection 
by B. burgdorferi. 
 
B1b cells from naïve and convalescent donor mice were MACS-purified so that ~22% of 
the transferred cells were B1b cells and T cells constituted <0.2%, B2 cells < 0.3% and 
B1a cells 1.5% (Figure 2, Table 5).  The cells were transferred into RAG1-/- mice and 
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four weeks after challenge, convalescent and naïve MACS-enriched B1b cells generated 
a pathogen-specific IgM immune response similar to one another.  The response was less 
than that seen with transfer of un-fractionated peritoneal cells from the previous 
experiment (Figure 13A). There was ~15-fold decrease in overall IgM titer in mice 
reconstituted with MACS-enriched B1b cells compared to reconstitution with un-
fractionated peritoneal cells (<15 units for MACS-enriched B1b compared to ~150 units 
for un-fractionated cells).  Only convalescent MACS-enriched B1b cells were capable of 
generating a pathogen-specific IgG response (Figure 13A).  
 
By assessing the specific IgG isotype responses we can infer whether a T-dependent or T-
independent response is occurring.  Furthermore, we can surmise the cytokine milieu that 
is generated since it is known that particular cytokines can induce switching to particular 
isotypes and will elucidate whether B1 cells are switching in a T-dependent or T-
independent manner.  Mice reconstituted with convalescent MACS-enriched B1b cells 
generated pathogen-specific antibody of all isotypes (IgG1: 10 units, IgG2b: 10 units, 
IgG2c: 0.5 units and IgG3: 4 units). These results suggest that prior antigen exposure of 
B1b cells during the initial infection in the donor mouse enhances the production of 
pathogen-specific IgG after transfer and challenge.  In addition, B1b cells generated in 
this fashion produce antibodies of multiple isotypes.  This introduces the possibility that 
B1b cells receive help from accessory cells in the peritoneal cavity, and so are capable of 
clearing spirochetes by many means due to the different effector functions from the 
various antibody isotypes. 
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Figure 13. Transfer of a population of peritoneal cells enriched for B1b cells from previously infected 
B6 mice confers partial protection from B. burgdorferi infection and DbpA is a prominent antigen 
recognized by reconstituted mice. Immunodeficient RAG1-/- mice were either unreconstituted (●, No 
Cells), or reconstituted with MACS-enriched B1b cells from the peritoneal cavity from uninfected (■, 
Naïve) or infected (▲, Convalescent) donors. Recipient RAG1-/- mice were challenged with 2x104 B. 
burgdorferi by i.d. injection, and at 4 weeks post challenge, sera and tissues were collected.  Data points 
represent individual mice, red lines indicate group means and bars are the SEM. A. Serum was titered for 
anti-B. burgdorferi, anti-DbpA and anti-BbGL-IIc antibodies by ELISA.  As a control, dilutions of serum 
from B. burgdorferi-infected donor mice were run in parallel, and dilutions of sample serum were 
normalized to the control serum which was defined as 100 antibody units.  Significant differences (p<0.05), 
determined by student’s unpaired T-test, are indicated by brackets.  B. 2-fold serial dilutions of immune 
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serum from C57Bl/6 donor mice 4 weeks after infection were immunobloted against lysates of B. 
burgdorferi (strain N40)  C.  Whole lysates of B. burgdorferi strain N40, B314 (--) (which lacks the 
endogenous plasmid that encodes DbpA/B), B314 harboring plasmids expressing either DbpA and DbpB 
(DbpA, DbpB) or expressing both plasmids (DbpAB), N40 lacking DbpA and DbpB (ΔdbpBA) and 
recombinant DbpA were probed with pooled serum at a 1:400 dilution, from RAG1-/- mice reconstituted 
with convalescent MACS-enriched B1b cells.  D. The bacterial burden was determined by qPCR of B. 
burgdorferi DNA relative to mouse DNA at 4 weeks post challenge.  Significant (p<0.05) differences were 
determined by the one-way ANOVA followed by Tukey’s post hoc multiple comparison test and are 
indicated by brackets. 
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Spirochete colonization of mice that received MACS-enriched B1b cells from previously 
infected mice was significantly diminished in the knee and heart by 16- and 5-fold, 
respectively, compared to unreconstituted mice (Figure 13B, “Knee” and “Heart”). 
Comparatively, bacterial loads were lowest in mice receiving convalescent un-
fractionated peritoneal cells (Figure 1) compared to mice reconstituted with convalescent 
MACS-enriched B1b cells: the bacterial copy numbers in the knee were: 34 ± 44.13 
copies, un-fractionated peritoneal cells, and 353.8 ± 157.8 copies, MACS-B1b; and in the 
heart: 8.13 ± 5.89 copies, un-fractionated peritoneal cells and 406.8 ± 212.2, MACS-B1b.  
This difference suggests that full immunological function in not reproduced with MACS-
enriched B1b cells.  Nevertheless, peritoneal cells enriched for B1b cells still generate 
significant protection against tissue colonization compared to unreconstituted mice, 
providing an opportunity to investigate the immunological response mediated by these 
cells.  Taken together, these results indicate that a population of cells that is enriched for 
B1b cells from the peritoneal cavity of naïve donor mice produce little pathogen-specific 
antibody and offer little, if any, protection against tissue colonization upon challenge in 
immunodeficient mice. In contrast, peritoneal cells from previously infected mice 
generate pathogen-specific antibody responses of multiple isotypes.  These cells also 
provide significant immunological protection. Taken together, these data indicate that 
B1b cells may contribute to clearance of B. burgdorferi and that, in the context of 
infection with B. burgdorferi, B1b cells require multiple encounters with antigen in order 
to make a robust IgG response. 
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The surface lipoprotein DbpA is a prominent antigen recognized by mice 
reconstituted with MACS-enriched B1b cells     
Since convalescent MACS-enriched B1b cells offered protection against colonization, we 
attempted to identify antigens recognized by the antibody response to B. burgdorferi.  To 
detect the protein antigens recognized by wild-type mice infected with B. burgdorferi, B. 
burgdorferi strain N40 extracts were subjected to western blotting using pooled sera from 
C57Bl/6 mice infected with B. burgdorferi strain N40 for four weeks.  When diluted 
1:2000, sera recognized at least six or seven prominent bands of apparent molecular 
weight between 17 and 40 kDa, similar to previous observations [33](Figure 13B, lane 
1).  To identify the most prominent antigen(s) in this set, western blots were 
simultaneously performed with serial two-fold dilutions (1:4,000 to 1:64,000).  We found 
that four species, with approximate apparent molecular weight of 17, 18, 25 and 40 kD, 
were each faintly detectable at the highest dilution tested.   
 
To determine the repertoire of antigens recognized by MACS-enriched B1b cells that 
provide a degree of immunological protection, extracts of B. burgdorferi strain N40 were 
western blotted with immune serum from the reconstituted and challenged recipients. 
This pooled serum recognized only three apparent species of ~16, 18 or 19 kD (Figure 
13C “N40 WT”, lane 5). This western blot profile differed strikingly from that generated 
using pooled sera from donor mice, in that the 25 and 40kDa species recognized by the 
donor mice sera were completely inapparent (compare Figures 13B and C). We infer 
that, not surprisingly, reconstitution of RAG1-/- mice with MACS-enriched B1b cells 
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results in a population of antibody-producing cells that is not identical to that found in the 
donor mice. 
 
The most prominent antigen recognized by reconstituted mice was of apparent molecular 
weight 19 kD.  This apparent molecular mass is consistent with that of the surface 
decorin-binding lipoprotein DbpA. Consistent with previous work [32, 34], we found that 
strain N40 DbpA was a prominent antigen recognized by pooled donor sera (Fig. 13C, 
lane 7, “DbpA” and indicated by arrow).  
 
T cells are not required for generating antibody to this bacterial protein [37], and 
immunization with recombinant DbpA induced protective immunity against needle 
innoculation [34], making DbpA an attractive candidate for the 19 kD antigen recognized 
by reconstituted mice. In fact, sera from these mice recognized recombinant DbpA (Fig. 
13C, lane 7, “rDbpA”).  This result indicates that the MACS-enriched B1b cells were 
capable of generating an anti-DbpA response, but did not definitively address whether the 
prominent ~19 kD species is DbpA. Evidence that the band was indeed DbpA came from 
immunoblotting two sets of recombinant B. burgdorferi strains that specifically differ in 
the expression of DbpA.  First, we found that the 19 kD species was absent upon 
immunoblotting the N40ΔdbpBA mutant (Figure 13C, “N40ΔdbpBA; lane 6).  Second, 
we found that the 19 kD species was absent upon immunoblotting strain B314 lacking 
DbpA (Fig. 13C,”B314”; lane 3). In contrast, the 19 kD species was apparent upon 
immunoblotting B314 derivatives that carrying shuttle vectors encoding either both 
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DbpA and DbpB, or DbpA alone ([27] Fig. 13C, “DbpAB” or “DbpA”; lanes 1 and 4, 
respectively).  A fainter band of ~18 kD was apparent when the sera were used to probe 
B314 expressing both DbpA and DbpB or DbpB alone (Fig. 13C, “DbpB”; lane 2), 
indicating that DbpB is likely also recognized by mice reconstituted with enriched B1b 
cells, albeit not to the extent of DbpA.  
 
To quantitate the anti-DbpA response, we performed ELISAs with purified recombinant 
protein. All mice reconstituted with convalescent MACS-enriched B1b cells made 
detectable anti-DbpA antibodies of the IgM and IgG isotypes (~ 5 and 3 units, 
respectively; Figure 13A. ‘rDbpA’) while mice reconstituted with naïve MACS-
enriched B1b cells produced low levels of IgM (< 1 unit) and no DbpA-specific IgG. 
 
We measured anti-B. burgdorferi antibodies of several isotypes (Figure 13A, “N40”), 
and wanted to determine if anti-DbpA antibodies were represented by multiple isotypes 
as well.  Among the specific IgG isotypes recognizing DbpA, IgG2b is the only one 
produced by all five mice reconstituted with convalescent MACS-enriched B1b cells (~6 
units; Figure 13A, “DbpA”).  Of the remaining isotypes, 2 out of 5 mice had detectable 
levels of IgG1 (3 units), 1 had IgG2c (<0.1 units), and 2 made IgG3 (5 units) against 
DbpA.  These results indicate that the MACS-enriched, DbpA-specific B1b cells undergo 
isotype switching during the response to B. burgdorferi and this response is largely 
comprised of IgG2b. Taken together, our data suggest that the DbpA lipoprotein is a 
major target of MACS-enriched B1b cells from convalescent mice, and that prior 
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exposure of these (convalescent) cells by B. burgdorferi infection in the donor results in 
higher levels of anti-DbpA antibodies during challenge of the recipient mice. 
 
Antibodies directed against B. burgdorferi glycolipid BbGL-IIc are generated by 
mice reconstituted with MACS-enriched B1b cells      
The IgM response to BbGL-IIc was readily detected when RAG1-/- mice were 
reconstituted with naïve or convalescent MACS-enriched B1b cells and challenged with 
B. burgdorferi (~90 units for each; Figure 13A, “BbGL-IIc”).  In contrast, the IgG 
response, as was the case when we measured antibody against whole spirochetes, was ~3-
fold higher in mice receiving convalescent B1b cells (Naïve:10 units, Conv: 27 units). 
Taken together, our data suggest that MACS-enriched B1b cells generate antibodies to 
the CD1d-restricted membrane glycolipid BbGL-IIc, and that cells from convalescent 
mice produce higher levels than naïve cells upon challenge in the reconstituted mice.  
   
Transfer of FACS-purified convalescent B1b cells from WT mice to RAG1-/- mice 
confers only marginal protection from B. burgdorferi infection         
MACS-enrichment of B1b cells did not eliminate all other peritoneal cell populations 
(Table 5), and these cells were likely contributing to antibody production and protection.    
To determine if the remaining non-B1 cells were contributing to antibody production and 
protection, we reconstituted RAG1-/- mice with 1.5x105 FACS-purified B1b cells from 4 
week-infected donor mice (Figure 3, Table 6), thereby eliminating all non-B1 cells.  
Four weeks after challenging the reconstituted mice with B. burgdorferi, we measured 
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antibody titers against B. burgdorferi.  Convalescent FACS-purified B1b cells made 
similar amounts of B. burgdorferi-specific IgM (Figure 14A, “N40”) compared to 
convalescent MACS-enriched B1b cells (Figure 13A; ~10 units for each).  However, B. 
burgdorferi-specific IgG titer was 10-fold lower in mice reconstituted with FACS-
purified B1b cells compared to MACS-enriched B1b cells (0.8 units).  We wanted to 
determine if there was a change in the IgG subclass distribution compared to MACS-
enriched B1b cells.  A loss of the generation of any isotypes could indicate the 
requirement for some peritoneal cell in stimulating B1b cells to generate antibody.  We 
did not detect IgG1 and IgG2c in any mice (data not shown).  B. burgdorferi-specific 
IgG2b was down about 10-fold compared to MACS-enriched B1b cells (0.5 units), and 
IgG3 was about~2.5-fold less than MACS-enriched B1b cells (2 units).  This decrease 
suggests that B1b cells are not fully capable of generating antibodies against B. 
burgdorferi in the absence of some stimulation from a peritoneal accessory cell.   
 
Western blots of pooled sera from RAG1-/- mice reconstituted with purified B1b cells 
showed a limited antigenic repertoire against extracts of B. burgdorferi N40 similar to 
that seen in mice reconstituted with MACS-enriched B1b cells.  This serum recognized 
three protein species of ~16, 18, or 19kDa (Figure 14B, “N40 WT”, lane 6).  The 19kDa 
species was absent upon immunoblotting the mutant strain lacking DbpA and DbpB 
(Figure 14B, “N40ΔdbpBA”; lane 5). Strain B314 carrying an empty shuttle vector 
contained no reactive species (Figure 14B, “B314 –”, lane 3), whereas pooled sera 
reacted strongly to the 19kDa band in B314 expressing both DbpA and DbpB or DbpA 
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Figure 14.  Transfer of FACS-purified convalescent B1b cells from WT mice to RAG1-/- mice confers 
only marginal protection from B. burgdorferi infection.  Immunodeficient RAG1-/- mice were either 
unreconstituted (●, No Cells) or reconstituted with FACS-purified B1b cells from infected mice (■, B1b).  
Recipient RAG1-/- mice were challenged with 2x104 B. burgdorferi by i.d. injection, and at 4 weeks post 
challenge, sera and tissues were collected.  Data points represent individual mice, red lines indicate group 
means and bars are the SEM.  A. Serum from RAG1-/- mice reconstituted with FACS-purified B1b cells 
was titered for anti-B. burgdorferi (upper panels) and anti-DbpA (lower panels) antibodies by ELISA.  As a 
control, dilutions of serum from B. burgdorferi-infected donor mice were run in parallel, and dilutions of 
sample serum were normalized to the control serum which was defined as 100 antibody units.   Significant 
differences, determined by student’s unpaired T-test are indicated by brackets. B. Whole lysates of B. 
burgdorferi strain N40, B314 (--) (which lacks the endogenous plasmid that encodes DbpA/B), B314 
harboring plasmids expressing either DbpA and DbpB (DbpA, DbpB) or expressing both plasmids 
(DbpAB) and N40 lacking DbpA and DbpB (ΔdbpBA) were probed with pooled serum, at a 1:100 dilution, 
from mice reconstituted with convalescent FACS-purified B1a (left panel) or B1b (right panel) cells.  
Serum from these mice reacts predominantly to B. burgdorferi DbpA, indicated by arrows.  C. The 
bacterial burden was determined by qPCR of B. burgdorferi DNA relative to 100ng of mouse DNA at 4 
weeks post challenge.  Significant (p<0.05) differences compared to unreconstituted mice were determined 
by the one-way ANOVA followed by Tukey’s post hoc multiple comparison test and are indicated by 
asterisk.    
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alone (Figure 14B, “B314, DbpAB or DbpA”, lanes 1 and 4, respectively). Sera 
reacted weakly to the barely detectable band of ~18kDa found in B314 expressing DbpB 
(Figure 14B, “B314, DbpB”, lane 2).  We conclude that, similar to the antibodies 
generated by MACS-enriched B1 cells, that antibodies generated by mice reconstituted 
with FACS-purified B1b cells recognize DbpA, and to a lesser degree, DbpB.        
 
Quantification of the anti-DbpA antibody response to DbpA by ELISA revealed that sera 
from mice reconstituted with FACS-purified B1b cells was weakly reactive to this 
antigen relative to the control serum. The mean antibody units for IgM, IgG, IgG2b and 
IgG3 were ≤ to 1 unit, and IgG2b was the only isotype that all mice produced (Figure 
14A, “rDbpA”).  IgG1 and IgG2c were not detected in any mice (data not shown). The 
antibody response generated by FACS-purified B1b cells from convalescent mice is 
barely above background, and the major protein antigen recognized is DbpA .     
 
To determine whether a purified population of B1b cells generated antibody against the 
glycolipid BbGL-IIc, we performed ELISA.  In fact, sera from mice reconstituted with 
FACS-purified B1b cells generated both IgM (~20 units) and IgG (5 units) (Figure 14A, 
“BbGL-IIc”).  Anti-BbGL-IIc IgM and IgG are diminished 4- and 5- fold, respectively, 
compared to sera of mice reconstituted with convalescent MACS-enriched B1b cells, 
suggesting that FACS-purified B1b cells are less efficient at generating antibody than 
MACS-enriched B1b cells. 
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Consistent with the low level of antibody production, FACS-purified B1b cells from 
infected mice offer marginal (3-fold) yet significant protection in the knee from B. 
burgdorferi challenge compared to unreconstituted mice; no protection against cardiac 
colonization was observed (Figure 14C, “Knee” and “Heart”). The B1b cells did 
produce low levels of anti-B. burgdorferi, anti-DbpA and anti-BbGL-IIc  antibodies, so 
we cannot rule out the possibility that a larger number of B1b cells would lead to some 
level of protection.  Nevertheless, the results suggest that some other cell type may 
collaborate with B1b cells to provide protection from challenge.   
 
Naïve T cells enhance the ability of peritoneal cells enriched for B1 cells to confer 
protection against B. burgdorferi tissue colonization in the knee 
Peritoneal cells, MACS-enriched B1b cells, and FACS-purified B1b cells all offered 
some level of protection to tissue colonization as well as antibody production.  However, 
as the transferred cells became more homogenous for B1b cells, the degree of antibody 
production and protection declined.  Bacterial loads were lowest in mice receiving 
convalescent un-fractionated peritoneal cells compared to mice reconstituted with 
MACS-enriched or FACS-purified B1b cells (bacterial load ± SD; Knee, un-fractionated 
peritoneal cells:  34 ± 44.13, MACS:  353.8 ± 157.8, FACS: 2660± 1626; Heart, Un-
fractionated: 8.13 ± 5.89, MACS: 406.8 ± 212.2, FACS: 815 ± 580).    Our data support 
the idea that B1 cells benefit from the presence of other cells, present in the peritoneum, 
for optimal activity towards combating Lyme infection.  Notably, FACS-purification 
eliminated all T cells and greatly decreased antibody production and protection from 
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challenge, indicating a possible requirement for T cells in clearing spirochetes from 
tissue. 
 
Reconstitution of immunodeficient mice with peritoneal cells from wild type or T cell-
deficient mice, and comparison of antibody response and bacterial load in T-deficient 
mice indicated an important role for T cells in diminishing bacterial burden (Figs. 6 and 
11).  As shown above, the administration of anti-CD40L antibody resulted in only a 
marginal (two-fold) increase in tissue colonization, one that (as shown above) can be 
accounted for by the enhancement of B2 cell function by T cell help. The muted effect of 
blocking CD40L-CD40 on antibody responses and bacterial burden suggests that B cell 
activation independent of CD40L provides the major functional element resulting in 
antibody production and clearance of spirochetes from the joint.  A prediction of this 
hypothesis is that naïve T cells, which have not previously been primed by B. burgdorferi 
infection, might be capable of promoting antibody production and immunological 
protection.  To test this, RAG1-/- mice were reconstituted with peritoneal cells, MACS-
enriched B1 cells alone, or MACS-enriched B1 cells with naïve or convalescent T cells 
so that all mice received ~2x106 B1b cells and 1x105 T cells when applicable (Table 7).  
 
Transfer of convalescent un-fractionated peritoneal cells (WT) resulted in significantly 
higher titers of B. burgdorferi-specific IgM (>1.7-fold) compared to B1 and B1 with 
naïve (N) or convalescent (C) T cells (WT: 173 units, B1: 35 units, B1+T(N): 58 units, 
B1+T(C): 99 units; Figure 15A, “N40”).  There were no significant differences in B.  
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Figure 15. Naïve T cells enhance the ability of peritoneal cells enriched for B1 cells to confer 
protection against B. burgdorferi colonization in the knee. Immunodeficient RAG1-/- mice were either 
unreconstituted (●, No Cells), or reconstituted with MACS-enriched B1 cells from infected donors (■, B1), 
B1+T cells from infected donors (▲, B1+Tconv), B1 cells from infected donors and T cells from 
uninfected donors (□, B1+T naïve), or un-fractionated peritoneal cells from infected donors (○,WT). 
Recipient RAG1-/- mice were challenged with 2x104 B. burgdorferi by i.d. injection, and at 4 weeks post 
challenge, sera and tissues were collected.  Data points represent individual mice, red lines indicate group 
means and bars are the SEM.  A. Serum was titered for anti-B. burgdorferi (upper panels), anti-DbpA 
(middle panels) and BbGL-IIc (lower panels) antibodies by ELISA.  As a control, dilutions of serum from 
B. burgdorferi-infected donor mice were run in parallel, and dilutions of sample serum were normalized to 
the control serum which was defined as 100 antibody units.  Significant (p<0.05) differences compared to 
WT mice were determined by the one-way ANOVA followed by Tukey’s post hoc multiple comparison 
test and are indicated by brackets.  B. Whole lysates of B. burgdorferi strain N40, B314 (--) (which lacks 
the endogenous plasmid that encodes DbpA/B), B314 harboring plasmids expressing either DbpA and 
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DbpB (DbpA, DbpB) or expressing both plasmids (DbpAB) and N40 lacking DbpA and DbpB (ΔdbpBA) 
were probed with pooled serum from mice which received WT (1:10,000), B1 (1:1,000), B1+T conv 
(1:4,000) or B1+T naïve (1:2,000).  Arrows indicate DbpA. C. The bacterial burden was determined by 
qPCR of B. burgdorferi DNA relative to 100ng of mouse DNA at 4 weeks post challenge.  Significant 
(p<0.05) differences compared to unreconstituted mice were determined by the one-way ANOVA followed 
by Tukey’s post hoc multiple comparison test and are indicated by brackets.  The asterisk designates this 
group as statistically different from all others.  
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burgdorferi-specific IgG between any of the groups, but B1 cells produced ~1.6-fold less 
IgG compared to B1 with naïve or convalescent T cells (WT: 145 units, B1: 78 units, 
B1+T(N), 126 units, B1+T(C): 141 units) suggesting that the addition of T cells increases 
the IgG antibody response of B1 cells and that T cells do not need to be activated prior to 
transfer to enhance B1 cells antibody response.  
 
Because of the slight reduction in total IgG response by B1 cells, we wanted to determine 
if any one isotype accounted for this difference.  There were no significant changes in B. 
burgdorferi-specific IgG1 or IgG3 (data not shown).  IgG2b was of special interest 
because this isotype was generated in mice reconstituted with MACS-enriched and 
FACS-purified B1b cells so seemed less dependent on the presence of T cells for its 
production.  As expected, there were no differences in IgG2b titers between any of the 
groups (WT: 170 units, B1: 106 units, B1+T(N): 152 units, B1+T(C): 159 units), 
indicating that the addition of T cells does not enhance the IgG2b response.   
 
 
 
 
 
Because IgG2c was barely detected in any of the MACS-enriched or FACS-purified B1b 
cell transfer experiments and only low levels were detected in TCRβxδ-/- mice in 
response to B. burgdorferi infection, we expected to see a T-dependent response in this 
experiment.  As expected, mice reconstituted with B1 cells (28 units) had a significant 
95 
 
 
reduction (~6-fold) of B. burgdorferi-specific IgG2c compared to mice reconstituted with 
B1 and convalescent T cells (173 units).  And while not significant, the B1 reconstituted 
mice were ~5-fold lower than un-fractionated peritoneal cell reconstituted mice (148 
units) and ~4-fold lower than B1 and naïve T cell reconstituted mice (106 units).  Taken 
together, these results suggest that T cells are not required for generating IgG2b yet are 
required for IgG2c production.   
 
We wanted to determine if the antigenic repertoire was affected by supplementing B1 
cells with naïve T cells instead of convalescent T cells.  Immunoblots with pooled sera 
from RAG1-/- mice reconstituted with un-fractionated peritoneal cells, B1 cells alone, B1 
cells with naïve T cells or B1 cells with convalescent T cells against lysed B. burgdorferi 
N40 all revealed a prominent band at ~19kDa (Figure 15, lane 5).  In addition, only 
difference between mice reconstituted with B1 and convalescent T cells or B1 and naïve 
T cells is the ~25kDa protein species present in B1 with convalescent T cells.  This result 
reinforces the idea that T cells do not need to be activated to provide help to B1 cells for 
antibody production.   
 
To confirm that the 19kDa band recognized by sera from all of the reconstituted mouse 
groups was DbpA we found that the band was absent in the mutant strain lacking DbpA 
and DbpB (Figure 15B, “N40ΔdbpBA”, lane 6) and in B314 carrying an empty shuttle 
vector (Figure 15B, “B314, --”, lane 3).  Sera from all of the reconstituted mice also 
reacted to bands in B314 expressing both DbpA and DbpB or DbpA alone (Figure 15, 
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“B314, DbpAB or DbpA”, lanes 1 and 4, respectively).  Furthermore, sera also reacted 
weakly to the ~18kDa band found in B314 expressing DbpB (Figure 15, “B314, DbpB”, 
lane 2).  The immunoblots revealed that DbpA and, to a lesser extent DbpB, are the 
predominant antigens recognized by mice reconstituted with un-fractionated peritoneal 
cells, B1 cells, B1 cells and naïve T cells and B1 and convalescent T cells.  
 
To quantitate the anti-DbpA response we used recombinant DbpA for ELISAs.  Transfer 
of convalescent un-fractionated peritoneal cells resulted in significantly higher titers of 
rDbpA-specific IgM (>7-fold) compared to B1 and B1 with naïve (N) or convalescent 
(C) T cells (WT: 359 units, B1: 11 units, B1+T(N): 57 units, B1+T(C): 49 units; Figure 
15A, “rDbpA”).  Sera from mice reconstituted with B1 and convalescent T cells had 
significantly higher titers of IgG compared to B1 and B1 and naïve T cell reconstituted 
mice; IgG was similar to un-fractionated peritoneal cells (WT: 133 units, B1: 56 units, 
B1+T(N): 65 units, B1+T(C): 212 units).  This suggests that prior activation of T cells 
enhances the overall anti-DbpA.   
 
Because of the differences observed in the total IgG response, we assessed the 
distribution of IgG isotypes to determine if a particular isotype was more dependent on 
the presence of activated T cells.  There were no significant changes in rDbpA-specific 
IgG1 or IgG3 (data not shown).  Similar to that observed for B. burgdorferi-specific N40, 
there were no significant differences in IgG2b titers between any of the groups (WT: 116 
units, B1: 62 units, B1+T(N): 81 units, B1+T(C): 130 units) suggesting that T cells are 
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not required for enhancing the DbpA-specific IgG2b antibody response.  As expected 
based from the results observed for B. burgdorferi-specific IgG2c, mice reconstituted 
with B1 cells (42 units) had a significant reduction (~4-fold) of B. burgdorferi-specific 
IgG2c compared to mice reconstituted with B1 and convalescent T cells (108 units).  And 
while not significant, the B1 reconstituted mice were ~2.5-fold lower than un-
fractionated peritoneal cell reconstituted mice (116 units) and about equivalent to B1 and 
naïve T cell reconstituted mice (58 units).  Taken together, these results suggest that T 
cells are not required for enhancing IgG2b yet are required for IgG2c production in 
recipient mice.  In addition, mice reconstituted with B1 and naïve T cells generate less 
antibody than mice reconstituted with B1 and convalescent T cells suggesting that 
encounter with antigen in the donor mouse enhances T cell help to B1 cells in the 
recipient mouse. 
 
Previous experiments demonstrated that the antibody response to BbGL-IIc is dependent 
on T cells (Figures 6A and 11A), so we wanted to determine if naïve and/or activated T 
cells enhanced the antibody response to this glycolipid.   Mice reconstituted with un-
fractionated peritoneal cells generated significantly more BbGL-IIc-specific IgM (> 3-
fold) compared to B1, B1 and naïve T or B1 and convalescent T cell reconstituted mice 
(WT: 905 units, B1: 87 units, B1+T(N): 304 units, B1+T(C): 283 units; Figure 15A, 
“BbGL-IIc”).  While not significant, mice reconstituted with B1 cells had 3-fold less 
BbGL-IIc-specific IgM compared to mice reconstituted with B1 and naïve or 
convalescent T cells.  These results imply that T cells are important for generating high 
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levels of anti-BbGL-IIc IgM.  Mice reconstituted with B1 cells had significantly less 
BbGL-IIc IgG compared to un-fractionated peritoneal cells and B1 and convalescent T 
cells and 2-fold less than B1 and naïve T cells (WT: 195 units, B1: 39 units, B1+T(N): 85 
units, B1+T(C): 152 units).  This suggests that T cells are important for enhancing the 
IgG response to BbGL-IIc and that activated T cells provide more help to B1 cells than 
naïve T cells. 
 
Mice reconstituted with un-fractionated peritoneal cells, B1 cells, B1 and naïve T cells 
and B1 and convalescent T cells all had significantly reduced bacterial burdens in the 
knee (Figure 15C, “Knee”).  In addition, mice reconstituted with B1 cells had 
significantly higher bacterial loads in the knee compared to un-fractionated peritoneal 
cells and B1 and naïve or convalescent T cells (at least 6.5-fold greater) suggesting that T 
cells, either naïve or convalescent, enhance B1 cells activity towards decreasing bacterial 
burden in the knee.  
 
Bacterial burden in the heart was significantly lower in mice reconstituted with un-
fractionated peritoneal, B1 and B1 with naïve or convalescent T cells compared to 
unreconstituted mice by at least 10-fold (Figure 15C, “Heart”).  This suggests that 
addition of T cells does not significantly enhance clearance in the heart, unlike in the 
knee. Taken together, these data suggest that while convalescent T cells may enhance 
some aspects of antibody production to a greater degree than naïve T cells (B. 
burgdorferi- and rDbpA specific IgG2c, BbGL-IIc-specific IgG), this difference does not 
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alter clearance of bacteria from the knee or heart.  Thus, T cells do not need to be 
activated to significantly contribute to B1 cells antibody production.  We confirmed that 
the addition of convalescent T cells to B1 cells enhances the antibody response and 
clearance of spirochetes in the knee in a separate experiment (Figure 16).  Although the 
difference in spirochete clearance from the knee between B1 and B1 and T cells did not 
reach statistical significance (11-fold difference), the trend was apparent (Figure 16B, 
“Knee”).   
 
Taken all together, these data demonstrate that B1b cells are capable of eliciting B. 
burgdorferi-specific immunological protection since they produce pathogen-specific 
antibody that is associated with protection against tissue colonization in the knee and to a 
lesser extent, the heart.  However, in contrast to protection seen with B. hermsii, 
protection generated by B1b cells greatly benefited from T cell help as seen by the 
increase of antibody production and clearance of spirochetes from the joint when T cells 
were present in the peritoneal transfer studies.  B1b cells are likely the cells eliciting 
protective antibody in the absence of T cells but this response is enhanced by CD40L-
independent T cell help.   
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Figure 16.  T cells enhance the ability of peritoneal cells enriched for B1 cells to confer protection 
against B. burgdorferi tissue colonization. Immunodeficient RAG1-/- mice were either unreconstituted (●, 
No Cells), or reconstituted with MACS-enriched B1 cells from infected donors (■, B1), B1+T cells from 
infected donors (▲, B1+Tconv) or un-fractionated peritoneal cells from infected donors (○, WT). 
Recipient RAG1-/- mice were challenged with 2x104 B. burgdorferi by i.d. injection, and at 4 weeks post 
challenge, sera and tissues were collected.  Data points represent individual mice, red lines indicate group 
means and bars are the SEM.  A. Serum was titered for anti-B. burgdorferi (upper panels), anti-DbpA 
(middle panels) and BbGL-IIc (lower panels) antibodies by ELISA.  As a control, dilutions of serum from 
B. burgdorferi-infected donor mice were run in parallel, and dilutions of sample serum were normalized to 
the control serum which was defined as 100 antibody units.  Significant (p<0.05) differences compared to 
WT mice were determined by the one-way ANOVA followed by Tukey’s post hoc multiple comparison 
test and are indicated by brackets.  B. The bacterial burden was determined by qPCR of B. burgdorferi 
DNA relative to 100ng of mouse DNA at 4 weeks post challenge.  Significant (p<0.05) differences 
compared to unreconstituted mice were determined by the one-way ANOVA followed by Tukey’s post hoc 
multiple comparison test and are indicated by brackets.  The asterisk designates this group as statistically 
different from all others. 
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CHAPTER III 
Discussion 
Lyme disease is a complex, multi-system infection that is especially dependent on the 
host’s ability to mount an effective humoral immune response and thereby limit pathogen 
burden. In this study, we attempted to identify those cells that contribute to this protective 
antibody response.  Previous work has shown that passive transfer of immune sera 
confers protection [16, 17].  B. burgdorferi encodes many targets of the humoral immune 
response, and one of the best characterized is DbpA.  Infected humans or mice generate 
antibodies to this protein [32, 33], and immunization with rDbpA or passive transfer of 
DbpA antiserum protects mice against infection [34-37].  A prominent non-protein 
antigenic target is an outer membrane glycolipid, BbGL-IIc, which is recognized by 
iNKT cells [47].  B. burgdorferi-infected mice that are deficient in iNKT cells suffer 
from chronic arthritis and decreased clearance of spirochetes from tissues [50].   
 
Antibodies directed against the Lyme disease spirochete have been associated with 
specific effector functions in vitro.  They can bind to the surface of the spirochetes to 
activate complement-mediated killing [18, 19], they promote opsonization and 
phagocytosis [20, 21], and some are directly bactericidal in the absence of complement 
[22, 23], causing death of the bacteria by disruption of the outer membrane [24].   
 
Antibodies have the potential to provide additional functions during infection.   For 
example, antibodies have the capacity to activate cells of the innate immune system, such 
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as neutrophils, natural killer cells and macrophages, via Fc receptors.  Each IgG subclass 
has different affinities for the different activating and inhibiting Fc receptors.  IgG2a and 
IgG2b are bound with the highest affinity to activating Fc receptors while IgG1 and IgG3 
have the lowest affinities [68].   
 
A poorly understood phenomenon is that even in the absence of tissue sterilization, 
antibodies directed against the spirochete can resolve arthritis and carditis [64, 69].  
Arthritis resolution is predominantly dependent upon the presence of B. burgdorferi-
specific antibodies [38, 39].  However, at least some part of carditis resolution is 
dependent upon a non-antibody-mediated mechanism [13, 38, 39, 41] which could 
involve macrophage phagocytosis of B. burgdorferi in the heart [42, 70].    
 
Because antibody is critical for generating protection against B. burgdorferi, the role of 
CD4+ T cells in Lyme disease has been extensively studied.  CD4+ T cells have been 
shown to be important for generating antibodies, decreasing bacterial burdens and 
reducing arthritis and carditis severity in mice [41, 44].   
 
Conversely, several studies have demonstrated that T cells are not required for protection.  
Mice deficient in CD4+ T cells due to a deficiency in MHC class II did not develop 
severe disease and generated protective antibodies [40].  Similarly, mice devoid of all T 
cells still generate protective antibodies, including antibodies to DbpA [33, 37]. 
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Experimental Strategy 
Although the role of antibody is critical for providing protection to B. burgdorferi, the 
cells involved in generating this protective response are currently unknown.  To address 
this issue and identify the B cells responsible for generating protective antibodies, we 
performed a series of mouse experiments. Our general strategy was to reconstitute RAG1-
/- mice (devoid of B and T cells) with subsets of B cells in the presence or absence of T 
cells.  The rationale for this was to determine whether defined populations of 
lymphocytes could confer protection to a mouse strain known to be susceptible to B. 
burgdorferi infection.  In addition, we wanted to determine if B cells were sufficient to 
generate antibodies in response to B. burgdorferi infection, or if T cells provided some 
measure of help.  Protection was defined as measurable amounts of pathogen-specific 
antibody that correlated with reductions in the number of B. burgdorferi colonizing joint 
and heart tissues.  To measure the effectiveness of our reconstitutions, we determined 
antibody responses by ELISA and bacterial clearance from the joint and heart by 
quantitative PCR.  In the presence of an antibody response, we were also interested in 
determining if there was a particular antigenic target, and we attempted to identify these 
antigens by immunoblotting.  We further attempted to determine the severity of arthritis 
and carditis.       
 
We first measured the level of tissue colonization in mice devoid of T cells to assess the 
role T cells might play in clearing spirochetes.  Previous work had not determined the 
precise contribution of T cells in preventing colonization, and we found that while both 
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wild type and TCRβxδ-/- mice harbor spirochetes in the joint and heart 4 weeks post 
infection, T cell-deficient mice have 10- and 50-fold more bacteria in the knee and heart, 
respectively.  This result indicates that T cells are required for efficient protection against 
colonization.   
 
We also examined the ability of naïve or convalescent un-fractionated peritoneal cells, a 
source rich in B1 cells, to confer protection to RAG1-/- mice upon challenge with B. 
burgdorferi.  Importantly, we found that reconstituted mice generated B. burgdorferi-
specific antibodies and these antibodies correlated with a significant reduction in the 
number of spirochetes compared to unreconstituted mice. 
 
One limitation to our methodology is how we inoculated the mice.  Previous reports have 
determined that route of infection (i.e. needle inoculation versus tick-infestation) may 
predict the outcome of the course of disease.  For example, DbpA immune serum protects 
naïve mice from needle challenge [37].  However, mice administered DbpA immune 
serum and then infected via tick-inoculation, which is the natural route of infection, were 
not protected [28].  Presumably, this is because DbpA is not efficiently surface expressed 
while in the tick vector [28] so that antibodies specific to this protein remain ineffective.  
Thus, we can not be sure we would see the same level of protection if we were to 
inoculate via tick transmission.   
 
Role of B. burgdorferi-specific antibodies 
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Since the primary effector function of B cells is antibody production, we wanted to assess 
the distribution of IgG isotypes, as there is no single isotype currently associated with B. 
burgdorferi clearance.  By determining the antibody isotype responses to B. burgdorferi, 
we could gain insight into the cytokine milieu during infection.  Typically, although not 
exclusively, IgG1 is induced by IL-4 during a T-helper type II (Th2) response, IgG2a and 
IgG3 are induced by IFN-γ during a Th1 response, and IgG2b is induced by TGF-β 
secreted by CD4+ cells and activated macrophages [71-74]. 
 
Furthermore, a comprehensive isotype analysis of the antibody response against B. 
burgdorferi could help determine if B1 cells generated a particular isotype that has well-
known functional properties.  For example, an IgG1 antibody directed towards the B. 
burgdorferi outer surface protein (Osp) B is directly bactericidal without the help of 
complement [22], and an OspA-specific IgG2b has been reported to cause opsonization 
leading to phagocytosis by macrophages [20].  Additionally, the principle functions of 
immunoglobulin Fc fragments have been well-characterized and particular isotypes are 
associated with specific effector functions: IgG1 and IgG3 participate in neutralization, 
IgG2a is efficient at opsonization, and IgG2b is a potent activator of complement, 
although these functions are not exclusive to these isotypes.     
 
Our ELISAs tested the antibody response to whole, intact B. burgdorferi N40 so that we 
were only detecting immune responses to surface exposed structures and not intracellular 
antigens (such as flagellin).  Antibodies directed against surface-exposed antigens may be 
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involved in effector functions that require surface activity (i.e. opsonization, complement 
activation, direct killing).  As discussed below, DbpA, a major antigenic target, and 
BbGL-IIc are surface exposed antigens.         
 
B1 B cells in protection against pathogens 
B1 cells contribute to protection against microbial organisms.  Work conducted on a 
related spirochete, B. hermsii, demonstrated that B1b cells are sufficient for resolution of 
the high, recurrent episodes of bacteremia in infected mice [75]. Upon infection with B. 
hermsii, peritoneal B1b cells undergo ~2-fold expansion [75].  T cells were not required 
for clearance of B. hermsii, and this observation was demonstrated in two important 
ways.  First, TCRβxδ-/- mice cleared bacteria as well as wild-type mice [75].  Second, 
transfer of convalescent, FACS-purified B1b cells from TCRβxδ-/- mice into RAG1-/- 
mice offered almost complete protection against challenge with B. hermsii  [56].  
Furthermore,  FO and splenic MZ B cell-deficient mice or B1a cell-deficient mice cleared 
B. hermsii from the bloodstream [56], eliminating the possibility that these cells are 
required for clearance.  Mice deficient in secreted IgM suffered non-resolving high levels 
of bacteremia,  and un-mutated IgM was the only antibody required for clearance of 
spirochetes [56].  Interestingly, adoptive transfer of peritoneal B1b cells from previously 
infected mice into immunocompromised RAG1-/- mice, which are unable to clear B. 
hermsii, allowed the mice to control the infection and prevented subsequent reinfection 
[56].  This demonstrated the ability of B1b cells to provide T-independent, long-term 
immunity that was dependent on their ability to make pathogen-specific IgM.   
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Hass et al [57] examined the role of B1 cells in generating pathogen-specific antibodies 
in a different bacterium, Streptococcus pneumoniae.   They found that S. pneumoniae 
induced B1 cells to generate pathogen-specific antibodies during mouse infections and 
specifically, B1a cells generated natural antibody that controlled the initial infection 
while B1b cells generated a protective immune response against the capsular 
polysaccharide. They further showed this response was largely T-independent because 
challenging RAG-/- mice adoptively transferred with purified B1b cells resulted in 
protective IgM and IgG3 antibodies. Although, it is possible that small numbers of T cells 
remained in the transferred B1b cell population because the donor mice did harbor T cells 
and they were not completely eliminated from the donor pool.  Therefore, the response 
generated by B1 cells to S. pneumoniae may not be entirely T-independent.  
 
In this study, we show that B1 cells play an important role during B. burgdorferi 
infection. We found that B1b cells underwent ~2-3 fold expansion in response to Lyme 
infection in C57Bl/6 (WT) and TCRβxδ-/- mice 4 weeks post infection (data not shown).  
This result nicely parallels previous work by Malkiel et al [58] where they measured a 
~2-fold increase in peritoneal B1b cells 9 days after infection with B. burgdorferi.  These 
results suggest that B1b cells may be capable of generating a pathogen-specific immune 
response upon infection with B. burgdorferi.   
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Reconstitution of RAG1-/- mice with un-fractioned peritoneal cells protected them from 
challenge with B. burgdorferi.  These mice had a significant reduction of spirochetes in 
the joint and heart compared to unreconstituted mice, and generated B. burgdorferi-
specific antibodies.  To more precisely identify the peritoneal cell subset contributing to 
protection to B. burgdorferi infection, we reconstituted RAG1-/- mice with naïve or 
convalescent MACS-enriched B1b cells.   Even when B1a, B2 and T cells were depleted, 
we saw a significant decrease in joint and heart bacterial loads and multiple isotypes of B. 
burgdorferi-specific antibody, but only in mice reconstituted with convalescent B1b cells 
in contrast to mice reconstituted with naïve B1b cells.  This result suggested that a 
positive response by B1b cells required prior activation or recognition of antigen during 
the initial infection in the donor mouse or that priming of B1b cells is responsible for 
subsequent protection.   
 
To further demonstrate that B1b cells could provide protection, we reconstituted RAG1-/- 
mice with FACS-purified B1b cells prior to challenge with B. burgdorferi.  Purified B1b 
cells elicited B. burgdorferi-specific antibodies of multiple isotypes and reconstituted 
mice had a significant reduction of spirochetes in the joint.  This result definitively 
demonstrated that B1b cells were capable of conferring some measure of protection 
against B. burgdorferi infection.   
 
One caveat of this study is that we cannot definitively conclude that B1b cells and not 
B1a cells were responsible for the generation of pathogen-specific antibodies because 
109 
 
 
later experiments made no attempt to sort B1a from B1b cells.  The rational for not 
sorting B1a and B1b cells is that attempts to reconstitute mice with FACS-purified CD5+ 
B1a cells were unsuccessful in that almost equal numbers of CD5- B1b cells were 
retained that were similar in number to those used to reconstitute with FACS-purified 
B1b cells.  However, mice that were reconstituted with the FACS-purified B1a cells 
(harboring nearly equal numbers of B1b cells) had an antibody response indistinguishable 
from that of B1b-reconstituted mice (data not shown).  Similarly, bacterial loads were the 
same in each group (data not shown).  From this we concluded that B1a cells were not 
contributing any additional response, so we made no attempts to further sort B1a from 
B1b cells in subsequent experiments. 
 
We are currently attempting to more precisely define the exact role of B1 and B2 cells in 
generating B. burgdorferi-specific antibodies by using allotype chimeric mice as 
previously described [76]. There are benefits to this system compared to reconstitution of 
RAG1-/- mice because RAG1-/- mice have defects in their splenic architecture and smaller 
than normal lymph nodes.  The chimeric mice may be particularly informative as these 
mice have an intact immune system.  In brief, Ighb allotype newborn mice will be treated 
with anti-IgMb to deplete all B cells; these will be the recipient mice, and will receive 
peritoneal cells (containing mainly B1 cells) from Igha mice. After the anti-IgMb 
treatment ends,  B2 cells from the recipient mice will be replenished.  After an additional 
6 weeks, these mice will be infected with B. burgdorferi for 4 weeks and antibody titers 
will be assessed.  Using allotype-specific antibodies we can track whether the serum 
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antibody response is generated by donor (B1) and/or recipient (B2) cells, and we plan to 
look at responses to B. burgdorferi, rDbpA and BbGL-IIc. Based on our results presented 
in this study, we predict that we will see a large contribution of B1 cells in generating a 
B. burgdorferi-specific antibody response, especially against DbpA.  There are a few 
limitations to this experiment: in addition to the recipient mice replenishing B2 cells, they 
are also likely to generate small numbers of bone marrow-derived B1b cells which could 
complicate interpretations of antibody titer data.  Furthermore, there are only 3 available 
allotype-specific antibodies available: IgM, IgG2a and IgG1, so we will not be able to 
assess the full isotype profile in these mice.     
 
Antibody response to B. burgdorferi antigens 
This study demonstrates that DbpA is the major antigenic protein target of B1b cells, as 
this was the predominant band detected on immunoblots from serum of RAG1-/- mice 
reconstituted with MACS-enriched or FACS-purified B1b cells.  DbpA is an important 
antigen because DbpA antiserum protects naïve mice from needle challenge and induces 
arthritis and carditis remission in infected SCID mice [34-37].    Additionally, DbpA 
antiserum induces arthritis resolution in infected SCID mice [37].  Previous reports have 
demonstrated that multiple isotypes of anti-DbpA antibodies are generated in the absence 
of T cell help [33].  B. burgdorferi-infected TCRβxδ-/- mice produce high titers of IgG3 
anti-DbpA antibodies and lower titers of IgM; no other isotypes were detected in T cell 
deficient mice, while IgG3 and IgG2b were the predominant isotypes made by wild type 
mice with lesser titers of IgM, IgG1, and IgG2a [33].        
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Importantly, treatment with DbpA antisera in SCID mice after they had been infected 
with B. burgdorferi was not sufficient to clear spirochetes [37] yet immune sera from 
TCRβxδ-/- mice was sufficient to reduce B. burgdorferi colonization [33].  This suggests 
that antibody directed against another antigen may be responsible for reducing bacterial 
colonization in the absence of T cells.  Because immune sera from TCRβxδ-/- mice 
reacted most strongly to rDbpA compared to multiple recombinant protein antigen [33] it 
is reasonable to infer that a non-protein antigen may elicit a protective antibody response 
in the absence of T cells.   
 
Anti-BbGL-IIc response 
We found that B1 cells generate antibodies to the B. burgdorferi glycolipid antigen,   
BbGL-IIc.  RAG1-/- mice reconstituted with MACS-enriched or FACS-purified B1b cells 
generated IgM and IgG responses against this glycolipid, suggesting that B1b cells can 
generate antibodies against multiple B. burgdorferi-specific antigens.  In subsequent 
experiments, IgM titers were not altered whether or not T cells were present.  In contrast, 
BbGL-IIc-specific IgG titers were statistically lower in all experiments when T cells were 
absent or depleted (Figures 6A, 11A, 12A and 15A, “BbGL-IIc”).  Thus, while B1 cells 
can generate antibodies to BbGL-IIc independent of T cells, the presence of T cells 
significantly enhances this antibody response.  
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A caveat with the ELISA used to measure the BbGL-IIc antibody response was that the 
antibody titer of reconstituted RAG1-/- mice was lower than or roughly equal to the titer 
of non-immune serum from C57Bl/6 mice used as a control.  An explanation for this 
effect is that immune competent mice have higher titers of natural antibody compared to 
RAG1-/- mice which are incapable of generating antibody.  The amount of pathogen-
specific antibody produced in a reconstituted mouse is much lower than the amount of 
natural antibody present in our control mice.  A better control would have been to use 
sera from RAG1-/- mice reconstituted with naïve cells.         
 
Anti-DbpA response 
Based on the previously reported anti-DbpA antibody response in TCRβxδ-/- mice [33], 
we expected to see IgM and IgG3 responses in mice deficient in T cells and potentially 
all IgG isotypes when T cells were present.  We carefully assessed the titer of each 
isotype from each mouse specific for DbpA and found that indeed some isotypes were 
only generated in the presence of T cells.     
 
Overall, RAG1-/- mice reconstituted with MACS-enriched B2 cells in the absence of T 
cells did not generate any detectable amounts of rDbpA-specific antibodies of any isotype 
indicating B2 cells do not produce anti-DbpA antibodies in a T-independent manner.  As 
such, these mice are excluded from the following discussion.   
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Anti-DbpA specific IgM titers were detected in all RAG1-/- mice reconstituted with B1 
cells or un-fractionated peritoneal cells from TCRβxδ-/- mice and in B. burgdorferi-
infected TCRβxδ-/- mice, which corroborates previous reports that anti-DbpA antibodies 
arise independent of T cells [33, 37]. However, the presence of T cells augmented the 
IgM response to DbpA suggesting that while T cells are not required to generate an anti-
DbpA IgM response, they enhance the ability of B1 cells to make this antibody.   
 
While T cells augmented the IgM response to DbpA, the absence of T cells did not result 
in significant decreases against B. burgdorferi N40 suggesting that IgM is not sufficient 
in providing protection since TCRβxδ-/- mice suffer from increased bacterial burdens in 
the knee and heart.  Furthermore, mice deficient in secreted IgM harbor indistinguishable 
numbers of  B. burgdorferi in the knee and heart compared to wild type mice (Figure 9), 
thus showing that IgM is not required for controlling B. burgdorferi infection.  However, 
we do not know whether serum from IgM deficient mice is protective or if they suffer 
from more severe arthritis or carditis since we did not test this.   
 
IgG1 was the least frequently detected anti-rDbpA isotype for all reconstitution 
experiments.  Serum from RAG1-/- mice reconstituted with un-fractionated peritoneal 
cells or MACS-enriched B1b, B1 with or without T cells and FACS-purified B1b cells 
were inconsistently positive.  These results suggest that B1 cells are inefficient at 
generating IgG1 anti-DbpA antibodies.  Furthermore, TCRβxδ-/- mice did not generate 
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antibodies of this isotype while wild type mice did, indicating that induction of DbpA-
specific IgG1 is dependent on T cells.  
 
As expected, anti-DbpA IgG3 antibody titers were readily detected in most mice.  IgG3 is 
most commonly associated with a T-independent response, and McKisic and Barthold  
have noted IgG3 anti-DbpA antibodies in the absence of T cells [33].  Furthermore, IgG3 
titers were virtually unaffected by the presence or absence of T cells in reconstituted 
RAG1-/- mice as titers were relatively the same for all groups.  Similarly, B. burgdorferi-
infected TCRβxδ-/- and WT mice had similar levels of DbpA-specific IgG3.  Thus, 
production of IgG3 antibody is not dependent on T cells.   
 
DbpA-specific IgG2c production was dependent on T cells.  RAG1-/- mice reconstituted 
with MACS-enriched or FACS-purified B1b cells had barely detectable serum levels of 
this isotype.  Additionally, mice reconstituted with B1 cells in the absence of T cells had 
statistically lower levels of this isotype compared to mice reconstituted with B1 and T 
cells.  Furthermore, TCRβxδ-/- mice made barely detectable titers of IgG2b while all B. 
burgdorferi-infected WT mice produced this isotype.   
 
The most impressive anti-DbpA isotype response was IgG2b.  This isotype was the only 
IgG subtype detected in all RAG1-/- reconstituted mice (except reconstitution with B2 
cells).  Interestingly, RAG1-/- mice reconstituted with B2 and T cells generated 
significantly lower titers of DbpA-specific IgG2b compared to mice reconstituted with 
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un-fractionated peritoneal cells (Figure 12A, “DbpA”) suggesting that B1 cells contribute 
substantially to the DbpA-specific pool of IgG2b antibodies in response to B. burgdorferi 
infection.  Based on these findings, one would predict that if IgG2b is preferentially made 
by B1b cells in the absence of T cells in reconstituted mice, then the DbpA-specific 
IgG2b response would remain unchanged with the inclusion of T cells in B1 cell-
reconstituted mice.  In fact, we saw no significant differences in DbpA-specific IgG2b 
responses whether mice were reconstituted with B1, B1 and T, or un-fractionated 
peritoneal cells (Figures 15A and 16A, “DbpA”).  However, IgG2b production is 
dependent on T cells because TCRβxδ-/- mice generate barely detectable levels of this 
isotype.  These differences imply that in order for B1 cells to generate detectable amounts 
of DbpA-specific IgG2b upon reconstitution in RAG1-/- mice, they require T cells to be 
present during the primary infection in the donor mouse to induce isotype switching.  
However, T cells are not required to induce production of IgG2b in the reconstituted 
mouse. 
 
One puzzling feature of the DbpA-specific IgG2b response is the significant difference in 
the amount of IgG2b generated between MACS-enriched B1b, FACS-purified B1b and 
MACS-enriched B1 cells (FACS B1b: ~0.5 units, MACS B1b: ~10 units, MACS B1: 100 
units).  All mice were reconstituted with similar numbers of B1b cells (Tables 5, 6, 7 and 
8) yet the overall titers seemed to decrease as the transferred cells became more pure for 
B1b cells indicating that some non-T cell peritoneal cell was contributing to enhancing 
the IgG2b response.   
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IgG2b has been shown to be induced by TGF-β [73], and a non-T cell present in the 
peritoneal cavity capable of generating TGF-β is the macrophage [74].  TGF-β typically 
suppresses the activation of lymphocytes and monocytes, but perhaps continual exposure 
to borrelial antigens may confer the ability to override this inhibitory effect.  Mice 
receiving MACS-enriched B1 cells received three times the number of IgM-, Mac1+ 
(peritoneal macrophages) compared to mice reconstituted with MACS-enriched B1b or 
FACS-purified B1b cells (data not shown).  This implies that macrophages from the 
donor mice, already activated because they have been exposed to antigen, could be 
enhancing the rDbpA-specific IgG2b antibody response.   
 
One way to test this would be to remove macrophages from the peritoneal cavity at the 
time of cell transfer and measure their ability to generate TGF-β.  Secondly, we could see 
if we could enhance the ability of FACS-purified B1b cells to make IgG2b by 
transferring increasing numbers of purified, activated peritoneal macrophages and 
determining if the increase in macrophages correlates to an increase in rDbpA-specific 
IgG2b.  
 
Alternatively, this difference in IgG2b production could be explained by the inclusion of 
B1a cells in the MACS-enriched B1 cell preparations, but we have shown that purified 
populations of B1a and B1b have no added antibody effect compared to FACS-purified 
B1b alone.   
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B1 cells require T cell help during B. burgdorferi infection 
In contrast to B1 cell functions in B. hermsii and Streptococcus pneumoniae, T cells are 
important for B1 cell activity during B. burgdorferi infections.  We demonstrated the 
necessity for T cell help in reducing spirochete numbers in the joint in a number of ways: 
1) as cells became more ‘pure’ for B1b cells (via MACS enrichment and FACS 
purification), there was a significant defect in clearance of bacterial burden in the joint 
compared to un-fractionated peritoneal cells unless T cells were present (Figures 13D, 
14C, 15C and 16B);  2) reconstitution of mice with un-fractionated peritoneal cells from 
TCRβxδ-/- mice did not protect against joint colonization, again confirming that T cells 
are required for optimal clearance (Figure 11C). 3) TCRβxδ-/- mice have increased 
bacterial burdens in the joint compared to wild type mice.   
  
The aforementioned results suggesting that T cells are important in generating protection 
to B. burgdorferi are in contrast to a previous study reporting that T cells are not required 
for generating a protective antibody response.  MHC II-deficient mice, which lack 
abundant numbers of CD4+ T cells [77], resolved arthritis and carditis similar to wild 
type mice [40].  Furthermore, immune serum from MHC II-deficient mice prevented 
infection in wild type mice and also cleared infection in infected SCID mice.  Together, 
those results imply that CD4+ T cells are not required for generating a protective 
antibody response to B. burgdorferi.  However, MHC II-deficient mice are not devoid of 
all T cells, including small numbers of CD4+ T cells [77], so this study does not rule out 
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a potential role for T cells in contributing to the development of protective antibodies 
during B. burgdorferi infection. 
  
In line with our evidence for the importance of T cells in enhancing the immune response 
during B. burgdorferi infection, immune sera from T cell-deficient mice does not have 
the same protective response as wild type sera [33].  Sera from TCRβxδ-/- and wild type 
mice conferred protection to naïve mice upon challenge [33].  In contrast, TCRβxδ-/- 
immune  sera did not resolve arthritis or carditis in SCID mice infected before passive 
immunization [33] unless ~2-fold more immune sera was used compared to wild type 
immune mouse sera [37].  The decrease in pathogen-specific antibody titer in the absence 
of T cells is similar to the weak antibody response made in RAG1-/- mice reconstituted 
with un-fractionated peritoneal cells from convalescent TCRβxδ-/- mice (Figures 11A and 
B).  While Barthold and colleagues clearly demonstrated that T cells are not required for 
generating antibodies capable of resolving arthritis and carditis, they did not quantify the 
number of bacteria in the joints or hearts to verify that disease resolution corresponded to 
bacterial clearance [33].  Thus, it would be important to know if immune sera from 
TCRβxδ-/- mice also enhanced clearance of spirochete from tissues as this would indicate 
if T cells are required for eliciting an antibody response capable of complete protection.  
Nevertheless, T cells are certainly important for enhancing the protective antibody 
response. 
 
119 
 
 
One notable caveat with reconstituting immunocompromised mice with lymphocytes is 
that we do not know what the optimal number of cells should be for reconstitution.  Since 
we did not see a decrease in spirochete clearance of the joint in RAG1-/- mice 
reconstituted with TCRβxδ-/- peritoneal cells, which correlated with a weak antibody 
response, it would be interesting to determine if increasing the number of transferred B1b 
cells would enhance the antibody response and subsequently result in increased clearance 
of spirochetes from tissues.  If disease resolution from TCRβxδ-/- serum correlates with 
spirochete clearance from those same sites of decreased inflammation, then it is 
reasonable to infer that increasing the number of transferred B1b cells from T cell-
deficient mice could enhance clearance in our reconstitution experiments. 
 
Tissue-specific requirement for T cells 
Interestingly, T cells seem to be more important for clearance of spirochetes in the joint 
than the heart.  The mechanisms of arthritis and carditis resolution are not fully 
understood but resolution of arthritis is almost solely dependent upon the presence of 
pathogen-specific antibodies as passive transfer of immune sera provided after infection 
of SCID mice resolved arthritis but not carditis [38, 39].  Conversely, resolution of 
carditis likely occurs in large part, independent of pathogen-specific antibodies as 
immune serum does not resolve carditis in SCID, B-cell-deficient or αβ T-cell deficient 
mice [13, 38, 39, 41].  In fact, macrophages can phagocytose B. burgdorferi [70], are a 
predominant cell population in Lyme carditis [42] and B. burgdorferi-infected mice 
deficient in recruitment of macrophages to the heart suffer from higher bacterial burdens 
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in the heart but not joint[78].  To further add to the complexity, induction of disease 
resolution and clearance of spirochetes may also be controlled by separate mechanisms 
because disease resolution is not necessarily indicative of bacterial clearance [64, 69].     
 
Our attempts at measuring arthritis and carditis resolution indicated the same degree of 
disease severity between wild type mice and TCRβxδ-/- mice previously reported 
[33](Table 10, “Un-reconstituted Infections”, WT compared to TCRβxδ-/-) indicating that 
T cells were not required for disease resolution, however the results were inconsistent 
among all the experiments and difficult to interpret.  Most likely this is a result of using 
C57Bl/6 mice which are known to be resistant to developing severe disease even when 
spirochetes are detectable in tissues [8]. 
 
In this study, clearance of spirochetes from the joint coincided with a robust pathogen-
specific antibody response that was dependent on T cells.  However, clearance of 
spirochetes from the heart was less dependent on antibody because RAG1-/- mice 
reconstituted with MACS-enriched B2 cells showed a significant reduction of bacteria 
from the heart compared to unreconstituted mice, in the absence of a detectable antibody 
response.  We found statistically significant decreases in the bacterial load in the heart in 
every experiment except when RAG1-/- mice were reconstituted with FACS-purified B1b 
cells.  Even mice reconstituted with B2 cells in the absence of T cells had a significant, 
albeit modest, decrease compared to unreconstituted RAG1-/- mice.  MACS-enriched B2 
cell-reconstituted mice had barely detectable levels of antibody (Figure 12A) indicating  
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a Groups of at least five mice (either reconstituted with lymphocytes or not reconstituted) were infected 
with B. burgdorferi and tissues were assessed for arthritis and carditis at 4 weeks post infection.  Severity 
of inflammation of knees and tibiotarsals joints (arthritis) was scored on a scale of 0 (negative) to 3 
(severe).  Prevalence is the number of mice with joint inflammation/total number of mice in a group.  
Carditis was scored as either active or inactive and is expressed as the number of mice with carditis/total 
number of mice in a group. 
     
b RAG1-/- mice were unreconstituted (No Cells), reconstituted with convalescent un-fractionated 
peritoneal cells (WT), convalescent MACS-enriched B2 cells (B2) or convalescent MACS-enriched B2 and 
T cells (B2+T). 
 
Table 9.  Comparison of arthritis and carditis among B. burgdorferi-infected 
immunodeficient RAG -/- mice reconstituted with lymphocytes or Bburg-infected un-
reconstituted micea. 
                 Arthritis               Carditis
                 (mean  ± Std. Dev.)        (number/total)
                Knee             Tibiotarsus               Heart
Mice Severity Prevalence Severity Prevalence Active Inactive
MACS-enriched B2, B2+Tb
WT 0.4 ± 0.55 2/5 2.3 ± 1.09 5/5 5/5  
B2 0.2 ± 0.45 1/5 1 ± 0.61 5/5  4/5
B2 + T 0.4 ± 0.55 2/5 1.6 ± 0.55 5/5 2/5 3/5
No Cells 0.2 ± 0.45 1/5 1.3 ± 1.15 5/5 2/5 3/5
Un-fractionated Peritoneal Cellsc
WT 0.8±.44 4/5 1 5/5 ndg nd
TCRβxδ-/- 0.6± .54 3/5 0.6± .54 3/5 nd nd
No Cells 0.8 ± 1.09 2/5 0.6± .54 3/5 nd nd
MACS-enriched B1, B1+Td
WT 0 0/5 0 0/5
B1 0.4 ± 0.54 2/5 0.2 ± 0.44 1/5
B1+T(N) 0.2 ± 0.44 1/5 2.0 ± 0.1 5/5
B1+T(C) 0.4 ± 0.54 2/5 0.4 ± 0.54 2/5 3/5
No Cells 0.4 ± 0.54 2/5 0.8 ± 0.83 3/5 2/5  
MACS-enriched B1, B1+Te
WT 0.4 ± 0.55 2/5 2.3 ± 1.09 5/5 5/5
B1 0 0/5 0.7 ± 0.84 3/5 4/5
B1+T 0.8 ± 0.45 4/5 1.3 ± 0.67 5/5 5/5
No Cells 0.2 ± 0.45 1/10 1.3 ± 1.15 5/5 2/5 3/5
Un-reconstituted Infectionsf
WT-MR1 0 0/5 0 0/5
WT   0 0/5 0 0/5
TCRβxδ-/- 0 0/5 .4±.89 1/5 1/5
RAG1-/- .8±.44 4/5 .2±.83 4/5 5/5
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cRAG1-/- mice were unreconstituted (No Cells) or reconstituted with convalescent un-fractionated 
peritoneal cells from C57Bl/6 (WT) or TCRβxδ-/- mice (TCRβxδ-/-).  
 
d RAG1-/- mice were reconstituted with convalescent un-fractionated peritoneal cells (WT), convalescent 
MACS-enriched B1 cells (B1),  convalescent MACS-enriched B1 and T cells (B1+T(C)) or MACS-
enriched convalescent B1 cells and naïve T cells (B1+T(N)). 
 
e RAG1-/- mice were reconstituted with convalescent un-fractionated peritoneal cells (WT), convalescent 
MACS-enriched B1 cells (B1) or convalescent MACS-enriched B1 and T cells (B1+T). 
 
f C57Bl/6 (WT), CD40L-treated C57Bl/6 (WT-MR1), TCRβxδ-/- or RAG1-/- mice. 
 
gnd, not determined. 
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that at least some portion of clearance of spirochetes from the heart may occur 
independently of a pathogen-specific antibody response.   
 
One possible mechanism for clearance of spirochetes in the absence of abundant 
pathogen-specific antibody would be that cells of the innate immune system, such as 
macrophages, could be phagocytosing spirochetes in the heart.  We cannot rule out that 
activated macrophages (or other innate cells found in the peritoneal cavity) from our 
infected donor mice were not transferred in conjunction with our MACS-enriched cell 
populations. Accordingly, macrophages could be contributing to clearance of spirochetes 
from the heart in this study when pathogen-specific antibody is lacking as B. burgdorferi 
does not require opsonization for phagocytosis by macrophages to occur [79].  To further 
support this idea, when we transferred FACS-purified B1b cells we no longer saw 
spirochete clearance from the heart (Figure 14C), which indicates that naïve macrophages 
from RAG1-/- recipient mice are not sufficient for controlling spirochetes numbers in the 
heart.  Similarly, MACS-enriched B1b cells from naïve donor mice did not contribute to 
significant reductions of spirochetes from the heart (Figure 13B). 
 
A way to test the contribution of macrophages in conferring protection to colonization 
would be to reconstitute RAG1-/- mice with a purified population of macrophages from B. 
burgdorferi-infected donor mice (source of “activated” macrophages).  To directly 
quantify the level of clearance, we would perform qPCR on heart samples from B. 
burgdorferi-infected reconstituted mice in parallel with infected unreconstituted mice.  If 
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macrophages are indeed contributing to clearance of spirochetes from the heart in the 
absence of pathogen-specific antibodies, we would expect a reduction in the number of 
spirochetes in mice reconstituted with activated macrophages.   
 
T cells provide CD40L-independent  help to B1 cells 
To more precisely define the role of T cells during B. burgdorferi infection, we wanted to 
determine whether T cells were providing non-cognate or cognate help to B cells. 
Previous work has shown that antibodies arise in the absence of T cell help [43].  Passive 
transfer of immune serum from B. burgdorferi-infected CD40L-deficient mice (CD40L-/-) 
conferred protection to infected SCID mice by clearing bacterial colonization and 
resolving arthritis and carditis.  Additionally, the antibody response directed against B. 
burgdorferi consisted largely of IgG2b and to a lesser degree, IgG2a, in CD40L-/- mice, 
indicating isotype switching occurs in the absence of CD40L-CD40 interactions.  
Importantly, while arthritis and carditis severity was comparable to that of wild type 
mice, B. burgdorferi-infected CD40L-/- mice do not clear bacteria from tissues.  
However, bacterial colonization was not quantified, so we can not know if T cell help 
was important for clearing bacteria.    
 
Just how T cells contribute to the B1 cell driven B. burgdorferi-specific immune response 
is not known.  While CD40L-CD40 interactions between T and B1 cells have been 
reported, they are not necessary for peritoneal B1 cells to undergo isotype switching [67].  
In our study, we found that inhibiting CD40L-dependent signaling did not result in 
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significant differences in joint and heart colonization compared to wild type mice and 
was significantly less compared to TCRβxδ-/- mice (Figure 12C).  Additionally, CD40L-
blocked mice maintained the ability to undergo isotype switching because they generated 
IgG2b and IgG2a antibodies directed against B. burgdorferi and DbpA (Figure 6A).  In 
contrast to B. burgdorferi infections in CD40L-/- mice [43], we detected B. burgdorferi-
specific IgG1 at titers comparable to wild type mice.  One explanation for this difference 
is that anti-CD40L treatment did not completely inhibit CD40L-dependent signaling, 
however our control experiment inhibited a known T-dependent antibody response by at 
least 10-fold (Figure 8).  Alternatively, the difference in IgG1 titers could be explained by 
technical discrepancies between experiments. Our infectious dose was twice as high, and 
they measured antibody titers at 60 days post-infection whereas we measured antibody at 
30 days.   
 
The modest increase in bacterial loads (although not significant) in CD40L-blocked mice 
compared to wild type mice, was most likely due to cognate B2:T cell interactions.  
RAG1-/- mice reconstituted with MACS-enriched B2 cells produced barely detectable, if 
any, B. burgdorferi-specific and DbpA-specific antibody and offered no protection to 
tissue colonization in the knee.  In contrast, B2 and T cells together restored the ability of 
the reconstituted mice to produce high titers of pathogen-specific antibodies and 
protected against joint colonization.  These results demonstrate that B2 cells need T cell 
help to contribute to the response to B. burgdorferi infection, presumably through typical 
B2:T cell cognate interactions with Type 1 (Th1) and T follicular helper (Tfh) cells .     
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These results further support the idea that B. burgdorferi-specific antibodies can be 
generated in the absence of CD40L-dependent T cell help.  B1 cells, largely recognized 
for their ability to generate antibody independent of T cells, require CD40L-independent 
help from T cells for enhanced protective responses to B. burgdorferi infection.   
 
Blocking CD40L-dependent T cell interactions had very little effect on antibody 
responses and bacterial burdens compared to wild type mice.  Because CD40L expression 
is up-regulated on T cells upon their activation, we can infer that naïve T cells, which 
have not previously been primed by B. burgdorferi, should promote antibody production 
and spirochete clearance to the same degree as primed T cells.  In fact, RAG1-/- mice 
reconstituted with B1 cells were able to significantly reduce spirochete numbers in the 
joint and the addition of naïve or convalescent T cells resulted in equally enhanced 
clearance.  However, we observed a slight defect in the ability of naïve T cells to equally 
enhance the antibody response to levels near that of mice reconstituted with convalescent 
T cells.  Namely, there was a significant difference in IgG directed towards rDbpA and, 
more modestly, IgG against BbGL-IIc.  Presumably, this reflects the activation status of 
the transferred cells.  T cells from convalescent donor mice have already had contact with 
antigen and are likely secreting effector molecules such as cytokines, to further stimulate 
B1 cells.  Nevertheless, the somewhat reduced ability of naïve T cells to stimulate 
antibody production by B1 cells did not significantly alter the ability of naïve T cells to 
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contribute to clearance of spirochetes from the joint, further supporting the notion that T 
cells enhance B1 responses independent of CD40L interactions. 
 
Model for iNKT cell interaction with B1 cells during B. burgdorferi infection 
Even though B1 cells are typically thought of as T-independent B cells, there is evidence 
that B1 cells respond to T cell help [54, 67].  Reconstitution of SCID mice with B1 and T 
cells induced an increase in antigen-specific antibodies compared to mice reconstituted 
with B1 cells alone [54], although no mechanism was defined for this response.  B1 cells 
can proliferate and secrete antibody in the presence of activated T-helper type 2 cells, 
CD40 stimulation in combination with IL-4 or IL-5 or with IL-5 alone [67].  Therefore, it 
is not unreasonable to infer that a population of T cells could be activating B1 cells to 
enhance protective responses during B. burgdorferi infection. 
 
iNKT cells are important immune cells during B. burgdorferi infection.  CD1d-deficient 
mice, which are deficient in iNKT cells, suffer from more severe arthritis and higher 
bacterial burdens [80].  Another mouse strain deficient in iNKT cells (Jα18-/-) suffered 
from chronic joint inflammation and a reduced ability to clear spirochetes from the heart 
and joint [50].  This group further showed that iNKT cells are activated in vivo after 
infection with B. burgdorferi and intracellular levels of IFN-γ and IL-4 were detected.  
iNKT cells may also play a role in mediating carditis resolution as well as clearance of 
spirochetes from the heart.  Jα18-/- mice suffered from more severe carditis and an 
increase in bacterial colonization in the heart [51].  Furthermore, wild type mice had an 
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infiltration of iNKT cells and activated CD1d-expressing macrophages in the heart, 
corresponding to an increase in IFN-γ gene expression in this tissue [51].   
 
It is likely that iNKT cells are contributing to the protection we see in this study.  BbGL-
IIc is a potent activator of both mouse and human iNKT cells, via recognition of this 
antigen presented on the CD1d molecule [47].  We have shown that B1 cells generate 
IgM and IgG against this antigen and that IgG titers were decreased in the absence of T 
cells.   
 
iNKT cells might be providing help in our studies  by providing the right cytokines to 
activate B1 B cells and promote their differentiation to plasma cells.  iNKT are known to 
produce a wide range of cytokines including IL-4, IFN-γ and IL-5 [45], and IL-4 derived 
from iNKT cells has been shown to co-activate B1 cells [81].  Furthermore, iNKT cells 
help increase pathogen-specific antibody responses to other microorganisms [82-84].  
The potential role for iNKT cells to enhance B. burgdorferi-specific antibody responses 
in our study is exemplified by looking at the IgG1 response.  B. burgdorferi-infected 
RAG1-/-  mice reconstituted with un-fractionated peritoneal cells from TCRβxδ-/- mice as 
well as B. burgdorferi-infected TCRβxδ-/- mice generate barely detectable levels (if any) 
of IgG1 (Figures 6A and 11A).  However, the presence of T cells, even with inhibition of 
CD40L, restores the ability of B. burgdorferi-infected mice to generate IgG1.  Isotype 
switching to IgG1 is largely driven by IL-4 [71] and iNKT cells readily produce IL-4 
upon activation.  Similarly, we have also shown that the B. burgdorferi-specific IgG2c 
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response is largely dependent upon the presence of T cells (compare MACS-enriched B1 
cells with or without T cells [Figures 15A and 16A])  and again is not decreased with 
inhibition of CD40L-dependent T cell help (Figure 6A).  Isotype switching to IgG2c 
commonly occurs in the presence of IFN-γ [71].  Thus, our data is consistent with a 
model in which B1 cells present antigen (BbGL-IIc) to iNKT cells, which in turn may 
provide cytokines that promote anti-B. burgdorferi antibodies. 
 
There are a number of ways to test if iNKT cells are capable of providing help to B1b 
cells during infection with B. burgdorferi.  First, we could reconstitute RAG1-/- mice with 
peritoneal cells depleted of iNKT cells or FACS-purified populations of B1b cells and in 
parallel use these same cell populations and also transfer FACS-purified populations of 
iNKT cells.  By measuring serum antibodies and bacterial loads in tissues we could 
assess the contribution iNKT cells may provide to B1b cells.  Furthermore, it would be 
interesting to see if we could detect any serum cytokines to determine what, if any, 
contribution they may provide in determining the antibody isotype response.  A second 
experiment would involve transferring FACS-purified populations of iNKT cells into T 
cell-deficient mice such as TCRβxδ-/- mice.  As controls we would have unreconstituted 
mice and wild type mice and would infect these mice with B. burgdorferi and measure 
antibody isotypes and titers, bacterial loads and potentially cytokine profiles.  It is 
possible that another T cell subset could be eliciting help to B1b cells, such as CD4+ T 
cells.  However, CD4+ T cells typically activate B cells via cognate and CD40L-
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dependent interactions, which we have shown are not required for B1b cell responses to 
B. burgdorferi.     
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APPENDIX 
Summary 
Circulating platelets typically are in a resting, relatively non-adhesive state, and become 
activated at sites of endothelial damage.  Platelet activation is associated with 
degranulation, the release of a number of bioactive products, and a dramatic increase in 
adhesiveness.  This enhanced adhesiveness is mediated in part by the surface localization 
of P-selectin, and a change in the conformation of the major platelet integrin, αIIbβ3.  In 
recent years, platelets have been postulated to fulfill an immune defense function.  
 
Borrelia hermsii, the causative agent of relapsing fever, is an arthropod-borne spirochete 
that causes severe bacteremia and thrombocytopenia. We previously showed that this 
spirochete binds circulating platelets during mammalian infection.  In vitro, B. hermsii 
efficiently binds platelets via integrin αIIbβ3, a receptor that is fully active only after 
platelet activation.  In addition to binding, HS1 vmp- a noninfectious strain that lacks the 
major surface protein, is capable of activating human platelets in a contact-dependent 
manner.  Here, we investigated the ability of infectious strains of B. hermsii to bind and 
activate human platelets.  We found that both infectious and non-infectious strains of B. 
hermsii bind to platelets efficiently.  However, despite robust platelet binding, only 
HS1vlp7, one of six tested infectious strains activated platelets. Strain HS1vlp7 was also 
the least capable of causing high level bacteremia.  Thus, in a collection of seven strains, 
there was an inverse correlation between platelet activation and infectivity, raising the 
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possibility that the infectious nature of B. hermsii includes the ability to avoid activating 
platelets.  
 
Given that integrin αIIbβ3 is a major receptor for B. hermsii, we tested whether an 
antibody directed against αIIbβ3 inhibited platelet activation by B. hermsii HS1 vmp-.  We 
found that in the presence of the antibody, even bacteria-bound platelets failed to 
efficiently activate.  In spite of the ability of antibody directed against αIIbβ3 to block 
activation, integrin αIIbβ3 was not required for platelet activation because B. hermsii HS1 
vmp- was able to activate αIIbβ3-deficient platelets.  This finding raised the possibility that 
another molecule, perhaps in close association with αIIbβ3, was directly involved in 
platelet activation.  CD9 is a tetraspanin that is associated with αIIbβ3 on the surface of 
platelets, and we found that anti-CD9 antibodies blocked B. hermsii binding even in the 
absence of αIIbβ3.   
 
Anti-CD9 antibodies are known to activate platelets by engaging CD9 with the Fab 
region and engaging FcRγIIa with the Fc region, thereby crosslinking the two receptors.  
This crosslinking is essential for platelet activation because anti-CD9 F(Ab)2 does not 
activate platelets. In addition, several gram positive bacteria have been demonstrated to 
trigger platelet activation by utilizing host IgG on the bacterial surface to interact with the 
platelet Fc receptor (CD32/FcRγIIa).  We found that the noninfectious B. hermsii strain 
HS1 vmp-, after growth in media supplemented with human sera, harbored human IgG 
on the bacterial surface.  In contrast, infectious B. hermsii strains did not detectably bind 
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IgG. This finding suggested that IgG on the surface of B. hermsii HS1 vmp- might 
mediate binding and activation of human platelets. In fact, we found that B. hermsii 
bound to FcRγIIa ectopically expressed on mammalian cells and to purified recombinant 
FcRγIIa.  Antibodies directed against CD9 or FcRγIIa inhibited binding to human 
platelets in vitro, and anti- FcRγIIa or anti-CD9 F(Ab)2 blocked platelet activation.  
Murine platelets naturally lack FcRγIIa, and as predicted, were not activated by B. 
hermsii in vitro, but acquired the ability to become activated by the spirochete with the 
ectopic expression of human FcRγIIa. These findings suggest that FcRγIIa is a receptor 
for B. hermsii and essential for the activation of platelets by non-infectious B. hermsii.  A 
simple model is that B. hermsii HS1 vmp- interacts with CD9 and FcRγIIa to activate 
resting platelets, leading to high levels of binding via the activation-specific receptor 
αIIbβ3 
 
To test whether platelet activation resulted in a phenotype during infection, wild type or 
FcRγIIa-transgenic mice were infected with strain HS1 vlp7, the sole infectious strain 
capable of activating platelets in vitro. Bacteremia and thrombocytopenia were 
indistinguishable between wild type and FcRγIIa-transgenic mice indicating that platelet 
activation via FcRγIIa does not detectably alter the course of disease.  
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? Integrin αIIbβ3 is not required for platelet activation by B. hermsii, but an 
antibody recognizing this receptor inhibits platelet activation. 
 
? Anti-CD9 antibodies inhibit B. hermsii binding to integrin αIIbβ3-deficient 
(Glanzmann’s Thrombasthenia) platelets. 
 
? Antibodies against CD9 or FcRγIIa (CD32) diminish binding of B. hermsii to 
platelets in vitro, and anti-FcRγIIa or anti-CD9(Ab)2 blocked platelet 
activation. 
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Figure A.1. Seven strains of infectious B. hermsii  bound to platelets but only one infectious strain, 
HS1vlp7, caused high levels of platelet activation.  B. hermsii strains HS1vmp- (non-infectious), 
DAHvsp2 (infectious), HS1vlp7 (low-level bacteremia), REN (infectious), SWA (infectious), RAL 
(infectious) and OKA (infectious) were incubated with purified platelets for 1 hour at MOIs of 10 or 20, 
fixed in 0.1% formalin and stained with 1:25 anti-CD61-PE (platelet marker, β3 integrin), 5µM SYTO-9 
and 1:100 Biotin-P-selectin (Platelet activation marker, CD62) followed by 1:300 Streptavidin Cy5-PE.  An 
isotype-matched control antibody (“(c)”) was used to verify p-selectin specificity on activated platelets.  
The number of bacteria bound to platelets (□,“Bacteria-Bound Platelets”) were defined as SYTO-9+ and 
anti-CD61+.  The number of bacteria-activated platelets (■,“Bacteria-Activated Platelets) were defined as 
SYTO-9+, anti-CD61+, and P-selectin+ and were quantitated by flow cytometry.  This graph represents 1 
out of more than 5 assays for the following strains: HS1vmp-, DAHvsp2, HS1vlp7; the remaining strains 
have only been tested once. 
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Figure A.2.  The non-infectious strain of B. hermsii , HS1vmp-, binds non-immune human IgG.  
B.hermsii strains HS1vmp- (non-infectious), HS1vlp7 (causes low level of bacteremia) and DAHvsp2 
(causes high level of bacteremia) were removed from fresh cultures of BSK media containing 12% human 
sera.  The bacteria were washed, fixed in 0.1% formalin and stained with 5µM SYTO-9 DNA-staining dye 
(green) and 1:20 dilution of rabbit-anti-human IgG (red).  The first column illustrates the bacteria (green), 
the second column illustrates bound human IgG (red), and the third column is the merged images of DNA 
and anti-human IgG. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
137 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure A.3.  B. hermsii binds to CD32.  A.  Radiolabeled HS1vlp7 spirochetes (low level bacteremia)  
were added  to empty wells (“No cell”), or to monolayers of CHO cells stably transfected with control 
vector (“Vector Tfxn”) or a vector expressing human CD32 (“CD32-expressing cells”).   Where indicated, 
anti-CD32 or isotype control antibodies  were added to wells prior to the addition of bacteria. After 
washing, the percent of bound bacteria in each well was determined.  Each bar represents the mean of four 
independent determinations +/- S.D. B. Radiolabeled HS1vlp7 spirochetes were added  to wells coated with 
MBP-tagged CD32 (“CD32”) or to wells coated with MBP alone (“MBP”). After washing, the percent of 
bacteria bound to each well was determined.  Each bar represents the mean of four independent 
determinations +/- S.D.  
 
 
 
 
MBP-CD32 MBP No Protein
0
2
4
6
8 p=0.0016
%
 o
f B
ac
te
ri
a 
B
ou
nd
0
5
10
15
20
p=0.0016
%
 o
f B
ac
te
ri
a 
B
ou
nd
Binding to CD32-expressing cells
Binding to recombinant CD32
No Cell Vector
Tfxn
-- Anti-
CD32
Isotype 
control
CD32-expressing cells
A.
B.
%
 o
f B
ac
te
ri
a 
B
ou
nd
%
 o
f B
ac
te
ri
a 
B
ou
nd
138 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table A.1. B. hermsii HS1 vmp- activates human platelets but not murine platelets unless they 
ectopically express human CD32.  B. hermsii strain HS1vmp- (non-infectious) was added to normal 
human, normal mouse or mouse platelets ectopically expressing human CD32 (“CD32-TG”) in the absence 
of agonist, or the presence of thrombin (agonist), or B. hermsii strain HS1.  The percent of bacteria-bound 
platelets were quantitated by flow cytometry.  To assess platelet activation, samples were stained with anti-
P-selectin antibody, and mean fluorescent intensity was determined. Platelet activation values were 
expressed relative to unbound thrombin-activated human platelets (“Bact-free plts”) defined as 1.00.  
Bacteria-activated platelets were determined by measuring the amount of P-selectin expression on platelets 
bound by bacteria (“% Platelets bound”).  NA: not assessed. 
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Figure A.4.  Model for platelet activation by B. hermsii.  1) B. hermsii, coated by non-immune IgG from 
growth media binds to integrin α2bβ3 and CD9, which is associated with integrin on the platelet surface.  2) 
Due to the proximity of CD32 to CD9 on the platelet surface, the non-specific IgG on B. hermsii activates 
CD32 via Fc receptor recognition. 3) Activation of the platelet leads to conformation changes in α2bβ3, 
making it highly adherent. 
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Figure A.5.  The expression of CD32 on mouse platelets does not have an effect on bacteremia or 
thrombocytopenia upon infection with a strain of B. hermsii, HS1vlp7, which can activate CD32 
transgenic mouse platelets in vitro.   Five CD32-transgenic (“CD32 Tg”) or five wild type (“WT”) mice 
were inoculated i.p. with 1x105 bacteria.  Consecutive tail bleeds were done every 12 hours.  5µl of blood 
was diluted 1:10 in anticoagulant (1M sodium citrate, 1M citric acid in Hepes buffer containing 0.1% 
dextrose, 0.2% BSA, pH7.4).  The blood was diluted to 1:100 and stained with anti-CD61-PE (platelet 
marker) and 1µM SYTO-9 (to detect bacteria).  After a 30 minute incubation, the samples were fixed in 
0.1% formalin and analyzed by flow cytometry for A. Bacteria per µl of blood and B. Platelets per µl of 
blood.   
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